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ABSTRACT 
A. terreus ATCC 20542 is a prolific fungi strain known for its ability to produce 
lovastatin, a potent cholesterol-lowering drug. Lovastatin is synthesised via type I 
polyketide pathway (PKS), a common pathway used to produce secondary metabolites 
in microorganisms. This pathway is also responsible for the production of two co-
metabolites of lovastatin, namely (+)-geodin and sulochrin. This study aimed to 
characterise the production of lovastatin and its co-metabolites, sulochrin and (+)-
geodin by A. terreus, and to investigate the relationship between lovastatin, sulochrin 
and (+)-geodin production using bio-waste crude glycerol (CG) as the substrate.  
The first part of this study investigated the effects of the major components of culture 
medium for the production of lovastatin, (+) -geodin and sulochrin, and pellet 
morphology. This investigation revealed that the types of carbon source have a major 
influence on lovastatin production, but not (+) -geodin and sulochrin. By contrast, the 
types of nitrogen source mainly influence (+)-geodin and sulochrin production. Of note, 
reasonable lovastatin production (25.68 mg/L), with high production of (+)-geodin (9.00 
mg/L) and sulochrin (22.35 mg/L) can be achieved using glycerol as the carbon source, 
and yeast extract as the nitrogen source. Further, culture with glycerol produced pellets 
with hairy morphology, which are optimal for the production of lovastatin, (+) -geodin 
and sulochrin. These results provide a basis for optimum culture conditions for 
subsequent experiments to study the production of metabolites by A. terreus. 
The second part of the study investigated the potential of crude glycerol (CG), a 
common bio-waste product from biodiesel industry, as the substrate for A. terreus 
cultivation and the production of metabolites of interest. At 30 g/L of CG, the 
  
 
production of (+)-geodin (13.14 mg/L) and sulochrin (14.79 mg/L) increased almost 2-
fold, with a significant inhibition of lovastatin production (~35% reduction)  when 
compared to pure glycerol (PG). The major contaminants from CG were then identified, 
and their effects on A. terreus’ growth and metabolite production were determined to 
further explain these observations. These studies show that the presence of 
contaminants in CG including saturated fatty acids (up to 48% reduction) and soap (up 
to 90% reduction) could contribute to the inhibitory effect of CG on lovastatin 
production, with no inhibition was observed on (+)-geodin and sulochrin production. 
Conversely, some contaminants, including double-bonded fatty acid such as oleic acid, 
methanol (MeOH) and salt (NaCl) could enhance lovastatin production up to 72%, with 
varying effects on (+)-geodin and sulochrin production. Partial purification of CG using 
solvent and activated carbon (AC) resulted in an improved yield of all three metabolites. 
This investigation revealed that CG can potentially be used to cultivate A. terreus, 
provided that sufficient purification is conducted on CG.   
Elicitor refers to a substance that provokes the microorganism’s defense system. The 
third part of this study investigated the effects of selected ‘elicitors’ on the production 
of lovastatin, (+)-geodin’s and lovastatin, and to elucidate the relationship between 
these three metabolites, if any. CG, which was subjected to partial purification by AC, 
was used for this part of the study, as the product purity was comparable to pure 
glycerol. In this study, the elicitors of choice were chemical elicitors such as sodium 
alginate, cholesterol, malonic acid, and physical elicitors such as shear force and 
viscosity. It was found that chemical elicitor stimulated the production of both 
lovastatin and sulochrin, with a lesser degree of stimulation on (+)-geodin’s production. 
On the other hand, (+)-geodin’s production was suppressed in the presence of high 
viscosity (<13 mg/L), whilst its production was significantly stimulated by high shear 
  
 
force condition (>500 mg/L). These observations indicate that lovastatin and sulochrin 
may play a role in A. terreus’ defense mechanism. Conversely, (+)-geodin may be 
important for fungal pellet integrity or immediate response to injury, as physical force 
greatly enhanced its production.  
In conclusion, CG is a promising alternative substrate for metabolite production by A. 
terreus, provided that sufficient purification and culture conditions are applied. This 
study, however, demonstrates no apparent relationship between the production of 
lovastatin, (+)-geodin and sulochrin by A. terreus using glycerol or CG as the substrate.  
Keywords: Aspergillus terreus; lovastatin; (+)-geodin; sulochrin; optimisation; crude 
glycerol; culture media;  
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A. Aspergillus 
CVD Cardiovascular disease 
TC Total cholesterol 
LDLC Low density lipoprotein cholesterol 
HDLC High density lipoprotein cholesterol 
HMG-CoA 3-hydroxy-3-methyl-glutaryl-coa 
PKS Polyketide synthase 
LNKS Lovastatin nanoketide synthase 
SAM S-Adenosyl-lmethionine 
LDKS Lovastatin nonaketide Synthase 
ORF Open reading frame 
VVM Volume per volume per minute 
PAI Plasminogen activator inhibitor 
CG Crude glycerol 
PG Pure glycerol 
MeOH Methanol 
NaCl Sodium chloride 
KH2PO4 Potassium phosphate monobasic 
MgSO4•7H2O Magnesium sulfate heptahydrate 
ZnSO4·7H2O Zinc sulfate heptahydrate 
CaCl2·2H2O Calcium chloride dihydrate 
FeCl3·6H2O Iron(III) chloride hexahydrate 
CuSO4·5H2O Copper(II) sulfate pentahydrate 
MnSO4 ·5H2O Manganese sulfate pentahydrate 
B Ml/grams  of hydrochloric acid 
C Catalyst factor 
W Grams of biodiesel 
ppm Per million grams 
ICP Inductively coupled plasma mass spectrometry 
v/v Volume/volume 
Wt/wt Weight/weight 
HPLC High performance liquid chromatography 
cDNA Complementary DNA 
PCR Polymerase chain reaction 
Ct Cycle threshold 
SEM Scanning electron microscope 
AS Ammonium sulphate 
SB Powdered soybean 
YE Yeast extract 
XFINAL Biomass final 
ØFINAL Diameter final 
C Metabolite titre 
OA Oleic acid 
PA Palmitic acid 
PE Petroleum ether 
  
 
DE Dietyl ether 
Tol Toluene 
AC Activated carbon 
WS Water softener pillow 
P Plant 
PC Plant cell culture 
F Fungi 
B Bacterial cell culture 
SA Sodium alginate 
SA2 Alginate without calcium ion 
MA Malonic acid 
  
 
 
1 
 
Chapter 1 – Introduction 
1.0 Aspergillus terreus ATCC 20542 
Aspergillus terreus ATCC 20542 is a filamentous fungus that can be found in soil. This 
fungus grows relatively well at room temperature (25 ºC) and usually produce a 
brownish colour that darkens as it ages on the culture plates (Figure 1.1). Similar to 
most fungi species, A. terreus possesses conidial heads that are compact, biseriate, and 
densely columnar. Its conidiophores exhibit hyaline and smooth-like appearance while 
its conidia are globose-shaped (Figure 1.1). A. terreus produced aleuriocnidia, a unique 
asexual spore that are thought to be the reason for its role in opportunistic infection [1]. 
A. terreus is commonly used in industry to produce several important metabolites for 
human consumption, such as itaconic acid, cis-aconitic acid, enzymes such as xylanase, 
and perhaps most importantly, lovastatin, a cholesterol-lowering drug.  
Lovastatin is a secondary metabolite, which is defined as low molecular mass, organic 
molecules that are not directly involved in their normal growth, development or 
reproduction. Although they are not as important as primary metabolites, their absence 
would probably cause long term defects in their ability to survive, reproduce or 
aesthetics of filamentous fungi [2]. To date, the function of each secondary metabolite 
in the natural environment remains unclear and varies with species. However, it is 
widely accepted that most secondary metabolites are expressed for competitive purposes 
and are important for their survival, such as defense against predator [3]. 
Apart from its valuable metabolites, A. terreus was selected for this investigation 
because of its advantageous trait as a fungus. Fungi can metabolise a variety of organic 
substrates such as starch, protein, lipid, ethanol, nitrates and ammonia more efficiently 
  
 
than most bacteria [4]. They also require fewer nutrients and supplements during 
growth, easier to cultivate, less susceptible to contamination and able to produce 
biomass with high nutritive value [5]. Most importantly, fungi have greater resistance to 
inhibitory compounds than bacterial species due to their considerably complex 
structure, attributed to their hyphae, cell wall, and extra-polysaccharide layer which 
provides extra protection to their organelles [5]. 
The scope of this review focuses on the fungus strain, mechanism of action and 
production, and currently available cultivation techniques for lovastatin production of A. 
terreus ATCC 20542. To a lesser extent, the production of its co-metabolites, (+)-
geodin and sulochrin will also be discussed.    
  
  
 
 
 
Figure 1.1: The photographs of A. terreus. (A) A. terreus cultivated on Potato 
Dextrose Agar at day 7 exhibited brownish colour that darkens as the cultivation 
proceeds; (B) Conidiophore/conidial head of A. terreus with spores on Rose Bengal 
Agar exhibited a hyaline-like appearance, photographed in Nomarski Differential 
Interference Contrast Microscopy. 
  
  
 
1.1 Lovastatin, a cholesterol-lowering drug produced by Aspergillus terreus 
ATCC 20542 
Among the most commonly prescribed drugs to lower cholesterol levels are statins [6]. 
Statins is a group of drugs that specifically inhibits 3-hydroxy-3-methyl-glutaryl-CoA 
(HMG-CoA) reductase, a rate-limiting enzyme involved in cholesterol biosynthesis in 
the liver. This effectively lowers the plasma low-density lipoprotein cholesterol (LDL, 
bad cholesterol), while increasing high-density lipoprotein (HDL, the good cholesterol) 
and inhibits the subsequent increase in hepatic LDL receptor expression [7]. 
Subsequently, it can reduce atheroma (accumulation and swelling of arterial walls), 
thrombus and atherosclerosis formation, improves endothelial function and suppressing 
inflammatory reaction [8]. Recently, preliminary studies also claimed that statins can 
potentially treat other conditions, such as osteoporosis [9], Alzheimer’s [10], and cancer 
[11,12].   
Commercially available statins can be grouped into three major types; natural, semi-
synthetic and fully synthetic. Lovastatin is a natural statin, largely produced by fungi 
through cultivation process. Statin was first isolated from fungal family, including the 
Aspergillus, Monascus and Penicillium family [13,14]. The first natural statin, 
compactin, was isolated in 1976 when a metabolite produced by Penicillium citrinum 
(Figure 1.2) was found to inhibit the activity of cholesterol precursor in rat liver extract 
[15]. Following this discovery, scientists from Merck performed their own screening 
and successfully isolated Aspergillus terreus ATCC 20452, which was used to produce 
the first commercialized statins, later named lovastatin [16]. The effectiveness of 
lovastatin was demonstrated in a large-scale, long term trial of 4444 patients that 
exhibited congenital heart disease with high plasma cholesterol, where a 30% reduction 
  
 
in all-cause mortality, 42% reduction in coronary death and 37% reduction in 
revascularisation procedures were reported [17]. The summary of the history and 
development of statins is illustrated in Figure 1.3. 
The discovery of lovastatin gave rise to other types of semi-synthetic and fully-synthetic 
statins, including atorvastatin (Lipitor), fluvastatin (Lescol) pitavastatin (Crestor) and 
simvastatin (Zocor). Pfizer, a large pharmaceutical company, reported US$12.4 billion 
in sale in 2008 alone from its atorvastatin (marketed under the brand name ‘Lipitor’) 
[18]. The gross sale for atorvastatin from the same company from 1996-2012 was 
reported to be in an excess of US$125 billion [18]. Similarly, Merck, the original 
company that discovered lovastatin, reported a sale of US$4.4 billion worldwide from 
simvastatin (under trademark name ‘Zocor’) in 2005 alone [19]. 
 
  
  
 
 
Figure 1.2: The micrograph of blue-green mold Penicillium citrinum. This strain is 
the first major compactin producing strain discovered in 1976 by Akira Endo and his 
team from among 6000 microbes screened. Adapted from [13]. 
 
  
 
 
Figure 1.3: The discovery, development and history of statins. Adapted from [16]. 
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• Discovery of compactin 
• Animal toxicity controversy 
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• Discovery of lovastatin 
1980 
• Lovastatin first effectiveness was described 
• Trials stopped for unknown reason, possibly due to toxicity 
1984 
• Trials resume 
• Toxicity was found only in extremely high doses 
1987 
• Lovastatin obtained approval from FDA and enters clinical use 
1990-1994 
• Statins effectiveness questioned due to limited data 
• Four 5-years trials showed highly positive results 
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• Withdrawal of cerivastatin due to side-effect  
2002 
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1.1.1 Mechanism of action of lovastatin 
Lovastatin lowers cholesterol levels by competitive inhibition. The biosynthesis of 
cholesterol involves a series of complicated reactions, initiated by the reaction between 
acetyl-CoA with actoacetyl-CoA, which forms HMG-CoA. Further reduction step by 
HMG-CoA reductase results in the formation of mevalonate compound. Various high 
energy reactions convert this compound to isopentenyl pyrophosphate, a precursor 
involved in many biological reactions in the human body, including cholesterol 
synthesis [20]. The acid form of the lovastatin is similar in structure to HMG-CoA 
intermediate, but with higher affinity for the HMG-CoA reductase, thereby allowing 
lovastatin to competitively bind to HMG-CoA reductase and renders it inactive (Figure 
1.4). This reaction prevents the conversion of 3-HMG-CoA into mevalonate by HMG-
CoA reductase, consequently block cholesterol biosynthesis. This mechanism of action 
is efficient and safe as it reduces the formation of complex and toxic intermediates [16]. 
The summary of the reaction is illustrated in Figure 1.5. 
  
  
 
 
 
Figure 1.4: The structural similarity of four different statins in comparison to 
mevalonate, an HMG-CoA intermediate. Adapted from [21]. 
  
 
 
 
Figure 1.5: The competitive inhibition by lovastatin of HMG-CoA reductase. 
Normal HMG-CoA conversion is depicted on the left while competitive inhibition is 
depicted on the right. Lovastatin competes with substrate (HMG-CoA) and preventing 
the formation of a product, mevalonate that is vital for cholesterol biosynthesis. 
Adapted from [16]. 
  
 
1.1.2 Biosynthesis of lovastatin in fungus 
The biosynthesis of lovastatin in A. terreus has been demonstrated using labelled 
precursors in a process known as polyketide pathway [22]. This process involves two 
acetate units merged to form two polyketide chains. The addition of methionine to this 
reaction results in the addition of methyl groups to the subsequent product. Further 
modifications are required to form lovastatin molecule as illustrated in Figure 1.6. 
Lovastatin biosynthesis involves several enzymes encoded by a gene cluster identified 
as type I polyketide synthase (PKS), which is commonly found in microorganisms that 
produce complex secondary metabolites. PKS may differ from one organism to another, 
as reviewed in [23] and [24]. The resulting metabolite produced may also be subjected 
to post-PKS tailoring steps that involve several other enzymatic reactions [25]. In 
lovastatin production, two main stages are involved; PKS (nine-step polyketide 
formation up to dihydromonacolin L) and post-PKS tailoring hydroxylation and 
oxidation steps (with molecular oxygen). One of the essential genes in this cluster is 
lovB, or lovastatin nanoketide synthase (LNKS). It contains seven active sites 
responsible for the arrangement of carbon skeleton in dihydromonacolin L and 
lovastatin. Another equally important gene, lovF, encodes for diketide synthase (DKS) 
in PKS, which handles the diketide synthase pathway. Characterization of these two 
genes (lovB and lovF) revealed the existence of methyltransferase domains in LKNS 
and DKS, indicating that methyl groups are being added (from S-adenosylmethionine) 
during polyketide biosynthesis [26,27].  
  
  
 
 
 
Figure 1.6: Biosynthesis of lovastatin in Aspergillus terreus in their acidic form [28].   
 
  
  
 
 
 
 
 
 
 
 
 
Figure 1.7: Organization of selected fungal PKS gene clusters in lovastatin 
biosynthesis. Abbreviations used: ORF – open reading frame; lov - genes responsible 
for lovastatin biosynthesis. 
This gene cluster also includes lovD, lovE, lovH, lovA and lovC genes with multiple 
open reading frames (ORF). They all play an important role in the regulation of 
lovastatin biosynthesis (Figure 1.7) [6]. Both lovE and lovH are necessary for the 
production of transcriptional regulatory factors based on the presence of a common Zn
++ 
motif. Both lovA and ORF 17 have been shown to encode for putative cytochrome 450 
monooxygenases, while lovC and lovD are important in assisting the correct chain 
formation of dihydromonacolin J [6]. 
ORF1 ORF2 lovA lovB (LKNS) lovG lovD ORF8 lovE ORF1
0 
lovC 
lovF (LDKS) ORF15 ORF16 ORF17 ORF18 lovH ORF14 ORF12 
Potential resistance gene 
Transesterase 
Transporter gene 
Regulatory genes 
Cytochrome 450 gene 
Unknown function 
Polyketide biosynthesis 
  
 
1.2 The factors that influence lovastatin production by Aspergillus terreus 
1.2.1 Dissolved gas and aeration rate 
An important parameter in the biosynthesis of lovastatin is dissolved gas concentration 
and aeration rate, which are closely related to each other. The effects of dissolved gas 
concentration and aeration rate can differ between some studies as different approaches 
and techniques were used for the fermentation. Furthermore, in certain cases where 
shake flasks (instead of bioreactor) were used, it usually lacks aeration control, and 
dissolved gas concentration is limited to controlling the speed of the shaking incubator. 
Lopez C. et al. (2004) attempted to overcome this problem by controlling the dissolved 
gas concentration in the fermentation chamber of shaking flasks using an enriched 
oxygen atmosphere while maintaining the sterility [29]. They found that high oxygen-
atmosphere (up to 80%) and aeration at 1 volume per volume per minute (vvm) 
produced a high lovastatin concentration, up to 300 mg/L. This study is also supported 
by another study showing that up to 70% dissolved oxygen may promote higher 
lovastatin production [30]. However, any higher concentration may reduce lovastatin 
production. Similarly, lack of oxygen (below 35%), may also significantly reduced 
lovastatin production[31]. Nevertheless, the mechanism that contributes to the increase 
in lovastatin production with increased oxygen content is still unclear, although it has 
been hypothesized that oxygen is essential for the post-PKS process in lovastatin 
biosynthesis [32]. 
While the effect of oxygen content on lovastatin production is generally similar across 
most studies, the effect of aeration is still under debate. Although the effect of aeration 
is often linked to the dissolved oxygen concentration, aeration provides an extra effect 
of shear force that may affect the fungus physiologically. The most obvious example 
  
 
was demonstrated by Porcel R. et. al (2005), where it was observed that aeration may 
cause the fungal pellet to change a number of its key morphological features [33]. 
Similar effects were not reported in the presence of high oxygen content. Higher 
aeration has been implicated with higher lovastatin production [34]. The increase is 
most likely due to the increase in oxygen intake, as high oxygen availability is 
important for lovastatin biosynthesis [35]. However, another study demonstrated the 
opposite and claimed that higher aeration enhances the formation of by-products such as 
(+)-geodin [36]. It has been argued that greater aeration may induce the post-PKS steps 
that lead to the formation of by-products, and ultimately reduces lovastatin production 
[36].  
1.2.2 The pH of the culture media 
pH is important as it regulates chemical reactions necessary for growth, metabolism and 
final product. For lovastatin production, there is a consensus on the optimum range of 
initial pH in the media, which ranges between pH 6 to 7 [36–39]. On the contrary, the 
pH profiles obtained during cultivation usually differ from one study to another as this 
is influenced by setup systems used (media, bioreactor, aeration and dissolved oxygen). 
pH fluctuations were observed when different carbon sources were used during 
cultivation [38]. For example, lactose-based media was shown to increase pH up to 7, 
followed by a gradual decrease towards the end of fermentation. In contrast, glucose-
based media caused a drop of pH down to 5.5 during the early stage of fermentation 
before increasing again to 6 [38]. In another study, Lai et al. observed that the pH drops 
faster in a bioreactor (24 hours) when compared to shake flask (48 hours), before 
increasing again [39]. An attempt to control the pH of fermentation using A. terreus did 
not meet with great success [40]. These fluctuations are thought to reflect typical fungal 
  
 
metabolism and any changes to this condition may lower lovastatin production [40]. 
However, pH control using a well-thought strategy was successful in improving 
lovastatin production. It was achieved by determining specific pH needed A. terreus at 
particular stages of cultivation and using only specific carbonates buffer. The carbonate 
buffer is hypothesised to be beneficial in forming malonyl-CoA, an important precursor 
for lovastatin biosynthesis [36].   
1.2.3 Fungal morphology 
A. terreus can grow either as pelleted or dispersed hyphae in submerged culture. It is 
generally accepted that increased efficiency of lovastatin production can be achieved 
with the pellet form of A. terreus [31,34,41]. Although the method  is still unclear, the 
formation of A. terreus pellet is thought be either from the single or aggregation of 
spores [42]. Pellet growth can be characterized by its diameter, filament ratio diameter 
(ratio of peripheral hairy surface with total area of the pellet), surface morphology 
(smooth or hairy) [33] and the ratio of active sites in the pellet [43].  
There are some debates about the effect of pellet diameter size on lovastatin production. 
While some studies have shown that larger pellet size, or diameter (>3 mm), is 
associated with higher lovastatin production [33,34], others have shown high lovastatin 
can also be achieved with small or medium size pellet (1.8 – 3 mm) [43,44]. This is 
thought to be due to the higher ratio of the active apical site in the smaller pellet in the 
context of its surface area [43], thereby improving the lovastatin biosynthesis. A similar 
study also suggested that the active apical ratio may determine the pathway of 
metabolite production such that the higher ratio favors lovastatin production while 
smaller ratio favors (+)-geodin (by-product) production. However, some studies argued 
that large diameter may result from increased oxygen intake by the fungus, which may 
  
 
enhance lovastatin production [32,34]. The effect of filament ratio diameter will not be 
reviewed as the impact towards lovastatin production is still unclear. 
The fungal morphology is also affected by several other factors including spore amount 
and sonication [43,45]. Larger spore amount (up to 10
10
/L) may produce more pellets at 
smaller sizes, thus increasing the lovastatin production [43]. The authors, however, 
never measured the production of lovastatin per pellets, which makes it difficult to 
determine whether small pellet produced higher lovastatin than the larger ones. The 
increase of lovastatin in the media was most likely due to the greater number of pellets 
in the culture as a result of higher initial spore number, as each pellet may contribute to 
lovastatin production. While sonication has been shown to improve metabolite 
production in other organisms [46–48], such an effect was not observed in A. terreus. In 
fact, sonication appeared to lower lovastatin production by approximately 28% [45]. 
Furthermore, intense sonication has also been reported to affect negatively the 
morphology of the fungus as the growth was shifted from pellet form to dispersed 
hyphae form. This morphological change is most likely the reason for the lower 
lovastatin production.  
1.2.4 Culture media 
Carbon and nitrogen are arguably the most important nutrients for fungi growth and its 
metabolite production. Carbon source is often associated with metabolite production, 
whereas nitrogen is essential for the growth of the fungus.  The choice of carbon source 
can vary between organisms and is dependent on various factors. Glucose is 
traditionally used as the main carbon source in most industrial fermentation due to their 
simple, growth-inducing and rapid utilisation nature. Although A. terreus can use 
glucose for their normal growth, this strain appears to favour a complex and slow-
  
 
metabolised carbon source, such as lactose or glycerol for lovastatin production [49]. 
The use of a rapidly-metabolized carbon source, such as glucose, may cause the 
formation of unwanted by-products, such as ethanol, with minimal lovastatin production 
due to possible catabolic repression [37].  
Carbon source 
(g/L) 
Nitrogen source (g/L) Lovastatin 
(mg/L) 
Strain  Reference 
Lactose (20) 
Sucrose (50) 
CSL (10) 
CSL (2.5) 
Soybean meal (2) 
400 
160 
TUB F-514 [50] 
Glucose (45) 
Lactose (53) 
 
Glucose (45) 
Glucose (45) 
Sodium glutamate (12.5) 
Peptonised milk (24) 
Yeast extract (2.5) 
Peptonised milk (24) 
Ammonium  
200 
120 
 
300 
0 
ATCC74135  [37] 
Glucose (15), 
maltodextrin 
(32), starch (20), 
lactose (N/A) 
CSL (5), yeast extract 
(2.5), peptonized milk 
(25) 
1200 Mutant 
strain of 
ATCC20541 
[51] 
Fructose (20) 
Glycerol (20) 
Lactose (20) 
Yeast extract OR 
sodium glutamate OR 
CSL (0.144 – 0.172) 
40 – 120  ATCC20542 [49] 
Glucose (45) Yeast extract (12.5) 12 ATCC20542 [52] 
Lactose (20) 
Lactose (5-40) 
Yeast extract (8) 
Yeast extract (2-12) 
35 
5-110 
ATCC20542 [53] 
Table 1.1: The use of carbon and nitrogen sources for lovastatin production. Note 
that there is no consistent amount of lovastatin being produced, as different 
experimental conditions were employed in each investigation. Abbreviation: CSL – 
corn steep liquor. 
It was reported that the lovastatin production can reach up to 5-fold higher with slowly-
metabolized carbon source compared to rapidly-metabolized carbon source [38]. 
Although the reason is still unclear, one possible explanation may be that complex 
carbon sources prolong the phase of secondary metabolite production in A. terreus. This 
hypothesis was supported by Lopez C. et. al (2003), when lactose was shown to produce 
higher lovastatin compared to the other carbon sources [49] (Table 1.1). However, using 
  
 
the same carbon source with different nitrogen source would give different lovastatin 
yield (Table 1.1). This observation suggested that the combination of the carbon and 
nitrogen source was probably more important than the rate of consumption itself. 
Furthermore, there were also instances when a good production of lovastatin can be 
achieved when glucose (a rapidly-metabolise carbon) was used [37,51]. Hence, further 
experimentation is probably required to validate the theory. The requirement for the 
type of carbon source might be stage-specific, such as the early growth of A. terreus 
requires rapidly-metabolised carbon while the latter stage of metabolite production 
requires slowly-metabolised carbon. This condition was demonstrated by Pecyna M. Et 
al (2011), when a mix of a rapidly- and a slowly-metabolised carbon sources produced a 
reasonably high lovastatin production [54]. 
In industrial fermentation, the use of complex nitrogen sources is unfavourable due to 
their high cost and low reproducibility. However, in case of A. terreus fermentation, a 
single nitrogen source, such as amino acids and ammonium ions did not give 
satisfactory lovastatin production [37,41]. The use of single amino acids such as 
histidine or sodium glutamate only produced several tens of milligrams per litre [37]. 
Although the fungus in culture commonly prefers ammonium ions as their nitrogen 
source, this option is not feasible for lovastatin production as this will acidify the 
medium and thus may inhibit the formation of lovastatin [41].  Most studies using a 
complex nitrogen source for lovastatin production, such as yeast extract, corn steep 
liquor and peptonised milk have met with greater success [34,37,49] (Table 1.1). 
Complex nitrogen sources generally comprised of various organic nitrogen compounds, 
which are mainly amino acids and proteins.       
  
 
Studies have also suggested that the ratio of carbon to nitrogen plays a role in lovastatin 
production. A higher ratio up to 41:3, may contribute to greater lovastatin production 
while a lower ratio may stimulate cell growth [49]. A study using lactose as a carbon 
source showed that lovastatin biosynthesis is limited by the amount of carbon source 
present in the media. The optimal amount of lactose (carbon source and yeast extract 
(nitrogen source) in that study was 20 g/L and 4 g/L, respectively [36].  Lopez C. et al. 
(2003) also reported that the highest production of lovastatin was obtained during the 
nitrogen-limited growth or starvation period [49]. This observation may be caused by 
the inhibitory characteristics of organic nitrogen in the media [53]. These views, 
however, are refuted by Hajjaj et al. [37]. In their study, they found that carbon 
starvation is more prominent in inducing lovastatin production, as they only observed its 
production  after the carbon was exhausted. All the studies mentioned, however, pointed 
to a similar conclusion that higher carbon to nitrogen ratios produce better lovastatin 
production.  
The presence of macro and micronutrients in the growth medium has also been shown 
to influence lovastatin production. These nutrients are not essential for the 
microorganism growth, but act as supplements to achieve better fermentation. Certain 
divalent metal cations (from mineral salts) such as Fe
2+
, Ca
2+
, Zn
2+
, Mg
2+
 and Mn
2+
 
were reported to improve the growth and lovastatin production [55]. In a more specific 
study conducted by Bizukojc et.al, his team postulated that certain vitamin B may 
enhance lovastatin formation by providing more precursors (for examples, NAD(P), 
FAD, coenzyme A and protein biosynthesis) for lovastatin biosynthesis. In his 
investigation, most of the vitamin B (riboflavin, pyridoxine hydrochloride, calcium 
panthothenate and nicotinamide) improved lovastatin formation. The improvement was 
further observed when the combination of vitamin B was used [56]. The addition of 
  
 
butyrolactone I, a self-regulating metabolite that stimulate lovastatin formation, to the 
culture of A. terreus has also been performed by Schimmel et al. Their study 
demonstrated that butyrolactone I increased the branched hyphae, the number of spores 
and the production of lovastatin. [57]. 
1.3 (+)-geodin and sulochrin in Aspergillus terreus  
Apart from lovastatin, A. terreus also produces a range of other secondary metabolites 
during its cultivation. This study is interested in two of these, namely (+)-geodin and 
sulochrin, and their production will be reviewed in this section. Although these 
compounds can also be found in other microorganisms, both (+)-geodin [58] and 
sulochrin [59] were originally isolated from A. terreus. 
1.3.1 (+)-geodin 
 (+)-geodin [(2R)-5,7-dichloro-4-hydroxy-6’-methoxy-6-methyl-3,4’-dioxospiro(benzo 
furan-2(3H),1’-(2,5)-cyclohexadiene)2’-carboxylate] is the primary co-metabolites of 
lovastatin. Hargreaves et al. (2002) managed to isolate and subsequently to predict the 
structure of (+)-geodin and their function [58]. (+)-geodin can be the most abundant 
metabolite found in A. terreus fermentation after lovastatin [22,60]. Both  lovastatin and 
(+)-geodin come from a similar pathway of polyketide synthesis, although their 
formation involves different molecules and products towards the end of their synthesis 
(Figure 1.8). Most of (+)-geodin’s formation involves octaketides (such as 
emodinanthrone) and uncharacterised octaketide synthase (such as emodinanthrone 
oxygenase) but none of these molecules are involved in lovastatin biosynthesis. While 
post-PKS process (oxidation and methylation) is also required in lovastatin formation, 
  
 
(+)-geodin’s formation requires additional post-PKS tailoring steps, which produce 
certain compounds such as emodin, questin, sulochrin and finally (+)-geodin.  
 
 
 
Figure 1.8: The biosynthesis of lovastatin, (+)-geodin and sulochrin. The labelled 
circles indicate the section where the specific reaction occurs. 1) Substrate (s) was 
taken. 2) The precursors for biochemical reaction inside A. terreus 3) The energy 
production. 4) The biomass production. 5) Lovastatin production. 6) (+)-geodin and 
sulochrin production and 7) itaconic acid production.  
  
 
In the clinical setting, (+)-geodin has been shown to inhibit plasminogen activator 
inhibitor (PAI-1), a molecule that is important in fibrinolysis mechanism and for the 
stimulation of glucose uptake in rat cells [61]. In term of A. terreus survival, (+)-geodin 
may act as mycotoxin [62], antiviral, antimicrobial and antifungal agent [58].  
Bizukojc M. et al. (2007) observed that (+)-geodin production is significantly 
influenced by the amount of initial carbon source in the media. The optimal amount 
reported ranges between 20 to 40 g/L for lactose, and an additional amount of lactose is 
required towards the end of the fermentation to improve its production. The production 
of (+)-geodin has been shown to be greatly reduced with insufficient carbon source or in 
the presence of high organic nitrogen concentration [60]. Supplements such as certain 
vitamin B (nicotinamide and riboflavin) have been shown to improve (+)-geodin 
production. [56]. (+)-geodin production also depends on the aeration rate [34,36]. Up to 
10-fold increase in (+)-geodin production was obtained with increased rate of aeration; 
however this negatively affects lovastatin production. It is currently unknown whether 
the increase of (+)-geodin caused the decrease of lovastatin, or the aeration itself is the 
cause. It was suggested that increased aeration stimulates oxygen uptake by cells, in 
turn improving (+)-geodin formation rather than lovastatin given that (+)-geodin 
production has higher oxygen demand [35].  
In terms of morphology, (+)-geodin production is not influenced by the ratio of filament 
ratio diameter. Instead, (+)-geodin production is more responsive to the change of 
diameter of the fungus pellet [43]. Further investigation revealed that bigger pellet is 
associated with the increase in the geodin active site which governs its production. 
Hence, by reducing the number of spores cultivated in fermentation, bigger fungus 
pellet can be obtained and subsequently increased (+)-geodin production [43]. 
  
 
1.3.2 Sulochrin 
Sulochrin [methyl 2-(2,6-dihydroxy-4-methylbenzoil)-5-hydroxy-3-metoxybenzoate] is 
another major co-metabolite of lovastatin. Referring to Figure 1.8, sulochrin is a 
precursor to (+)-geodin. In the clinical setting, sulochrin was shown to inhibit the 
activation of human immune cell (eosinophil), endothelial cells and certain cytokine 
release (IL-8 and LTC4). Their function for A. terreus survival, however, is not very 
well-documented. Sulochrin was only mentioned briefly to act as an antibiotic [63]. As 
one of the primary co-metabolite of lovastatin production, sulochrin is thought to be 
unneeded in fermentation, due to its possible role in competing with lovastatin 
production [64]. Compared to (+)-geodin, the research regarding sulochrin production is 
much limited. It is said that the production of sulochrin is stimulated by the presence of 
butyrolactone I, another metabolite that is also produced by A. terreus [57]. 
Interestingly, as discussed before, butyrolactone I is also the major metabolite that 
induce the formation of lovastatin. Hence, eliminating sulochrin production might 
improve lovastatin production by reducing the competition. However, further 
experiment to characterise their production should be done as their link with lovastatin 
production is still unclear, whether the synthesis of these metabolites would inhibit, 
compete, or induce more lovastatin.  
  
  
 
1.4 Summary of literature review findings, knowledge gap, and proposed 
investigation 
This literature review indicates that culture media play an important role in dictating the 
production of metabolites by A. terreus. To date, a standard media conditions for the 
cultivation of A. terreus is lacking. Therefore, the first part of our study aimed to 
optimise the basic media for metabolite production by A. terreus. In particular, selected 
salts, spore condition and nitrogen sources would be tested for their capability to induce 
lovastatin production. 
The most important media optimisation involved the effect of different carbon sources, 
particularly carbohydrates, on the production of lovastatin, (+)-geodin and sulochrin. 
The literature review indicates that the preferred carbon source for lovastatin production 
is slowly degradable carbon sources, such as lactose and glycerol [49]. However, other 
researchers have also showed that fast-utilised carbon sources, such as glucose, may 
also produced a good amount of lovastatin (refer Table 1.1). This disagreement may be 
caused by different cultivation techniques or conditions. Thus, more detail work will be 
done to access whether the rate of carbon utilisation is important for lovastatin 
biosynthesis by A. terreus.  
A. terreus is easier to cultivate, less susceptible to contamination and have greater 
resistance to inhibitory compounds compared to bacterial species [5]. These 
characteristics allow us to utilise the cheap and unused dirty substrate from industrial 
by-products, such as CG. The culture of this fungus on this dirty substrate has never 
been attempted before. A. terreus has been previously demonstrated to produce itaconic 
acid from glycerol [65,66], but its ability to produce lovastatin from CG is unknown. In 
  
 
this study, crude and pure glycerol would be used to measure the level of inhibition 
caused by the presence of contaminants. Subsequently, the effect of contaminants on 
culture performance will be assessed using partially purified CG.  
Based on the literature, two of the most profound co-metabolite of lovastatin are (+)-
geodin and sulochrin which are derived from a separate polyketide pathway involved in 
lovastatin formation. (+)-geodin and sulochrin are often found in large amounts. 
However, their relationship with lovastatin production is still unclear. We assessed the 
growth of A. terreus and the production pattern of these metabolites in the presence of 
selected “elicitors” which are chemical or physical factor that can provoke the defense 
system of the fungus. For this investigation, the chemical elicitor selected are sodium 
alginate, cholesterol, and malonic acid, whereas the physical elicitor selected are the 
shear force. These experiments would, hopefully, provide a better understanding of the 
relationship between these three metabolites. 
 
 
  
  
 
1.6 General and specific objectives of thesis 
The overall aim of this thesis is to measure the production of lovastatin, (+)-geodin and 
sulochrin by A. terreus under different conditions. 
The specific objectives of this project are: 
a) To study and prepare the optimal media composition for A. terreus cultivation 
b) To determine the best carbon sources for the production of lovastatin 
c) To conduct a pilot study on the effectiveness of bio-waste crude glycerol on the 
growth of A. terreus 
d) To induce and establish a relationship between the production of lovastatin, (+)-
geodin and sulochrin using elicitors 
e) To evaluate the general morphology of A. terreus under different treatments  
 
  
  
 
Chapter 2 - Materials, methods and optimisation 
2.1 Description of crude glycerol used in the study 
CG samples were kindly provided by Biodiesel Producers Limited (Melbourne, VIC). 
The plant used a mixture of tallow and used cooking oil to produce biodiesel. The CG 
exhibits dark yellow colour and has a pH of 7. The CG was stored in a sealed 
aluminium container at room temperature. Depending on the type of experiment 
conducted, the CG was either filtered to remove the undissolved contents, autoclaved to 
remove methanol or vigorously shaken to evenly distribute all the contents. 
The determination of the major CG contents was done in our lab using MSDS sent by 
the company as a reference. Glycerol content was determined using glycerol 
calorimetric detection reagent from Sigma-Aldrich (refer section 6.5.2: Glycerol 
calorimetric detection). Methanol (MeOH) was determined using the 
spectrophotometric method [67]. In short, 100 ml of 10% sodium nitroprusside was 
mixed with 10% potassium ferricyanide and 5% sodium hydroxide as the main reagent 
in a plastic container. The solution was then diluted to a total of 600 mL of chromogenic 
solution. This reagent was protected from light at 4 ºC. The sample to reagent was 
mixed at 1:5 ratios. The sample was shaken gently before incubation at room 
temperature for 15 minutes. The absorbance of the sample is measured using Cary 50 
Bio UV-Vis Varian spectrophotometer at 485 nm.  
Sodium chloride (NaCl) was determined using commercially available kits (LaMotte, 
Maryland, USA). The kit used titration method to determine the amount of NaCl. Soap 
content was determined using a simple chemical titration method. Isopropyl alcohol 
(100 mL), which was used as a solvent, was added to 10 g of sample (CG). While 
  
 
stirring the solution, a few drops of bromophenol blue indicator solution were added to 
measure the pH. The beaker was weighed and followed by the addition of 0.01M HCl 
buffer solution until the colour of the solution turns from blue to yellow. The final 
amount of soap was calculated based on the differences of weight: 
sampleofGrams
soapofGrams
Wx
CxB

1000
01.0
 
Where: 
 B = ml (or grams) of 0.01N HCL added. 
 C = Catalyst Factor (320.56 for KOH, 304.4 for NaOH) 
 W = grams of biodiesel in solution (should be 10g) 
The final result can be obtained by multiplying the equation by one million to get grams 
of soap per million grams (ppm) of the sample.  
To determine the safety of CG, inductively coupled plasma mass spectrometry (ICP) 
was used to determine the heavy metals content in CG (refer section 2.5.3: Inductively 
coupled plasma mass spectrometry).  
 
  
  
 
2.2 Pre-treatments of crude glycerol  
 Several pre-treatments were performed to improve the overall quality of CG used in the 
cultivation. The pre-treatments include solvent washing, activated carbon washing, 
reduction of water hardness and free fatty acids removals.  
The pre-treatment using solvent washing was performed to dissolve hydrocarbons 
present in CG. Different non-polar solvents (hexane, heptane, octane and petroleum 
ether) were used to wash the CG at room temperature using 1:1 volume ratio, followed 
by shaking at 200 rpm. After three hours of mixing, it was centrifuged at 3000g for 
2 minutes to separate the mixture into two distinct phases, that is, the upper phase of 
solvent and the lower aqueous phase of glycerol containing residual impurities. The 
lower phase was subjected to washing again with fresh solvent and the process was 
repeated to collect the final treated CG. 
The second pre-treatment involved the use of activated carbon purchased from MARS 
Fishcare North America (PA, USA). The CG used in this pre-treatment was diluted with 
the same volume of deionised water to reduce its viscosity. Around 20% (wt/v) 
activated carbon was added directly to the diluted samples, following the incubation at 
200 rpm at room temperature for 3 hours. The samples were later centrifuged at 3000g 
for 15 minutes, and the deposit (activated carbon) was removed to obtain the CG.  
Fatty acids removal was done according to Sneha et. al [68]. CG was diluted in water 
(1:3 ratio) and was vortex vigorously. Next, the pH of the solution was adjusted to 4 by 
using hydrochloric acid to convert the soluble fatty acids into insoluble fatty acids. The 
residue was then separated from crude glycerol after centrifugation at 3000g for 15 
minutes. Finally, the CG was readjusted to pH 7 using sodium hydroxide.  
  
 
2.3 Culture conditions 
The fungal strain used in this study is Aspergillus terreus ATCC 20542. The fungal 
strain was restored according to the supplier’s recommendations (Cryosite Distribution 
Pty Ltd, Sydney, Australia). The tip of the fungal vial was heated before applying a few 
drops of water to crack the tip. The cracked tip can be broken easily to expose the inner 
vial that contained the fungus. The freeze-dried fungus was then rehydrated with 1 mL 
of sterile deonised water for 2 hours before transferred to and maintained on potato 
dextrose agar at 30 ºC for 7 days. The spores were harvested with 0.001% (v/v) tween 
80 in sterile deionised water and kept at 4 ºC until further use. The spore can also be 
stored for long term used by adding 15% glycerol and kept at -80°C. The spore numbers 
were determined using a haemocytometer. Spore suspension was adjusted to 10
7
 
spores/mL before inoculation in 125 mL Erlenmeyer flasks with a total volume of 50 
mL culture media. 
The spores were grown at 185 ± 5 rpm and a temperature of 30 ± 1°C in a shaking 
incubator. The basic basal medium was used for the experiments (0.4 g/L KH2PO4, 0.2 
g/L MgSO4·7H2O, 0.4 g/L NaCl, and 0.001 g/L ZnSO4·7H2O), unless stated otherwise. 
Yeast extract was used as the sole nitrogen source at 4.0 g/L (10 % wt/wt of N and 9% 
wt/wt of C)[49]. The pre-culture was prepared in a similar basal medium, but with 
lower carbon source (10 g/L) and higher nitrogen source (yeast extract) at 8 g/L to drive 
the growth of the fungus between 24 to 30 hours to allow the fungus to achieve 
exponential growth before cultivation. The fungus was used for cultivation when the 
diameter of the fungus pellet reached 1.5 ± 0.5 mm, measured using a digital calliper. If 
the solution turns cloudy without visible pellet growth, the culture was considered 
  
 
contaminated and should be discarded. The day of the pre-culture is considered as Day -
1.  
The transfer of fungus pellet from pre-culture media to culture media involved several 
steps (in a sterile condition). A sterilised strainer was used to recover the fungus from 
the pre-culture flask and washed with sterile deonised water twice. The fungus collected 
was then transferred to a new flask with the appropriate culture medium. All the process 
was done either under the fume hood or by the Bunsen burner.   
2.3.1 Shear pressure study 
The basic culture conditions are as described in Subsection 2.2: Culture Conditions, 
with slight modification. Instead of using a shaking incubator, the flasks were incubated 
in a water bath at 30 ± 1°C, followed by shaking at 150 rpm. To create the effect of 
friction, a small piece of linen cloth (5 x 5 cm) was placed at the bottom of the flask. To 
create the effect of sonication, a sonicator head (UP400S, Hielscher Ultrasonics, 
Germany) was carefully placed into the water bath. The sonication is performed 
continuously for the whole duration of the experiment at 40 kHz. 
2.3.2 Bacterial-induced elicitation study 
The flask containing the contaminated pre-culture media was removed from the shaking 
incubator and plated on the PDA plate. The bacterial growth was kept at 30 ± 1°C in the 
incubator. If needed, the bacteria colony can be harvested using sterile deonised water 
and added to the culture medium.   
  
 
2.4 Fungal biomass dry weight determination 
The biomass yield was determined gravimetrically. Fungus biomass was recovered by 
filtration using No. 2 Whatman filter paper and washed twice with distilled water, 
followed by drying at 80 ºC for 24 hours or until a constant weight is achieved.  
2.5 Bioreactor study 
The bioreactor (Real Time Engineering Pty. Ltd., Australia) with 2 to 5 L working 
volume was agitated by a two-level mixing impellers (radial flow) and a Boehm Frame 
23 motor with a speed range of 0-1200 rpm. A manual peristaltic pump was used for pH 
control which can be controlled by a relay switch on its power connection. Two feed 
pumps (Grundfors Alldos DMS-A) with maximum flow rates of 2.5 and 7.5 L/h were 
used. The feed pumps were calibrated before use according to the manufacturer’s 
instructions. Both the speed of the mixing impellers and feed pumps can be set 
manually or via an analogue signal. A simple vacuum pump (240 V) with a sterile filter 
was used for air supply. 
The bioreactor medium pH was measured by an AppliSens Z001038510 pH probe. 
Dissolved oxygen in the medium was measured using an AppliSens Z010059020 
oxygen probe. The volume of dissolved oxygen was fixed at 70%. Adapters to fit to 19 
mm ports were used for both probes. A resistance temperature detector served as a 
temperature sensor in the bioreactor. Critical foam levels were measured using a 
conductivity sensor attached to the bioreactor. 
Julabo MB-5 water bath with integrated thermostat was used for the heating and cooling 
of the bioreactor. The water from the Julabo was circulated through the metal jacket 
  
 
until the intended temperature (30 ± 1°C) was achieved. Communication with this 
device was accomplished using an RS 232 interface. Julabo MB-5 was also used for 
calibration of the thermometer. 
Signals from probes, the thermometer and the conductivity sensor were amplified by a 
FermTx amplifier. Inputs from the amplifier were gathered over an NI FP-AI-110 
analogue input module. Analogue outputs for feed pumps and the stirrer motor were 
generated by an NI FP-AO-200 analogue output module. Relay outputs for the air pump 
and the pH pump were produced by an NI FP-RLY-422 relay module. Communication 
with these modules was achieved by an NI FP-1601 network module, which was 
connected to the computer via Ethernet. All analogue signals ranged from 4 to 20 mA.  
The bioreactor interface was designed using National Instruments (NI) LabVIEW 7.0. 
A NI FieldPoint 4.0 driver package was installed to enable communication with the 
Fieldpoint Ethernet module. PID control blocks were taken from the NI LabVIEW PID 
and Fuzzy Logic toolkit. A LabVIEW Visual Interface (VI) for the communication with 
the heating/cooling device via an RS 232 interface was made available upon request by 
Julabo Labortechnik GmbH, Seelbach, Germany. The full schematic of the bioreactor is 
shown in Figure 2.1, and the hardware setup is shown in Figure 2.2. 
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Figure 2.1: The schematics/design of signal processing in a bioreactor. Dashed lines 
represent the signals while continuous lines correspond to physical connections, i.e. 
pipes. Signals from sensors are amplified and sent to the PC (1). The PC displays the 
values and calculates corresponding output signals (2). The output signals are sent to the 
different hardware components (3). 
  
  
 
 
Figure 2.2: The setup of the bioreactor for the cultivation of A. terreus. In A), the 
bioreactor/hardware configuration is shown. In B) the major external hardware is 
shown. 
 
2.5.1 High-performance liquid chromatography (HPLC) 
Quantification of lovastatin was carried out by High-Performance Liquid 
Chromatography (HPLC), Agilent 1200, using a UV detector at a wavelength of 238 
nm, with a reference wavelength of 360 nm to confirm the analysis. The column used 
was XDB Eclipse Zorbax C-18 at 30˚C with sample chamber temperature at 4˚C, a flow 
rate at 1.0 mL/min, an injection volume of 10 µL and 95% acetonitrile and 0.1% 
phosphoric acid solution as mobile phases. The lovastatin standard was prepared from 
the commercially available lovastatin tablet (Lovastin, YSP Industries, Malaysia). The 
tablet was crushed into fine dust and dissolved in 0.1 M MeOH and sodium hydroxide 
solution (1:1 by volume), heated for 20 minutes, and neutralised with 0.1 M 
hydrochloric acid [49]. The standard is held at 4°C until needed. The modification step 
  
 
is essential to convert the lactone form of lovastatin into an acidic form, which is 
produced in excess in fermentation. The (+)-geodin and sulochrin standard was 
purchased from Sapphire Bioscience (Sydney, Australia). Sulochrin, (+)-geodin and 
lovastatin appeared at a retention time of around 4, 7 and 10 minutes, respectively, in 
the HPLC chromatogram.  
2.5.1.1 Optimisation of HPLC analysis 
To simplify the analysis of all the metabolites, a standard method that can 
simultaneously detect all three metabolites of interest at the same time was developed. It 
is important to minimise the time required to analyse each sample and reduce the 
preparation time due to the sensitivity of the sample to alteration in temperature. Using 
the optimised method (refer to Materials and Methods: Section 2.5.1), we successfully 
identify each of the metabolites of interest under similar conditions. To measure the 
concentration of the intended metabolites in the samples, standard curves were 
generated by performing serial dilutions of the standards, as shown in Figure 2.3.  The 
peaks of interest are depicted in Figure 2.4.  
  
  
 
 
 
 
Figure 2.3: The standard curves of three metabolites produced by A. terreus. A) 
Lovastatin, B) (+)-geodin and C) sulochrin. These metabolites are analysed using HPLC 
under similar conditions.  
 
  
 
 
 
 
 
 
Figure 2.4: The peaks of lovastatin, 
(+)-geodin and sulochrin in HPLC 
chomatogram. The peaks can be 
easily identified in the untreated 
sample of fermentation Note that 
lovastatin and (+)-geodin would break 
down into additional compounds over 
time, as shown in the (B) and (C). 
Sulochrin (D) was shown to be more 
stable as no breakdown was observed 
even after 3 months in the storage. 
The original and control 
chromatograms are available in the 
appendix section. 
  
 
As the lovastatin tablet was manufactured by pharmaceutical company, their lovastatin 
content is in the form of lactone as this form is more stable and readily convertible to 
hydroxyacid (active) form upon entering the human gastric juice. Using the previously 
described treatment (refer to section 2.5.1), HPLC analysis showed that no lactone form 
was detected, as all of them was successfully converted to the hydroxyacid form. 
Although the analysis of Yang DJ et al. showed the formation of lovastatin methyl ester 
when this method is used, our analysis did not show any presence of this compound 
(Figure 2.4) and in control chromatogram (in Appendix) [69]. The peak produced was a 
single, clean peak at a retention time of around 10 ± 1 minutes (which could change 
slightly over time due to the age of the column or inaccurate mobile phases mixture). 
Our finding are in agreement with a few other authors [49,60]. Our treatment was also 
shown to produce a stable hydroxyacid solution for a few months at 4 °C. However, 
fresh solution or standard is recommended to be prepared every three months as our 
analysis showed the breakdown of lovastatin to an unidentified compound, which is 
possibly its methyl ester form as shown in Figure 2.4.  
No further modification was performed on (+)-geodin and sulochrin sample, apart from 
the addition of 100% methanol. Clean peaks at retention time of 4 ± 0.5 minutes 
(sulochrin) and 6 ± 0.5 minutes (+)-geodin) were detected (Figure 2.4). Both of these 
standards were shown to be only stable to be stored in -20°C. Hence the analysis of 
fermentation sample was done rapidly to avoid the loss of this metabolite. Subsequent 
analysis showed that (+)-geodin can break down to the unidentified compound after 
three months, while sulochrin is still stable. In terms of fermentation sample, no further 
treatment was shown to be needed for the samples in preparation for the HPLC analysis. 
HPLC peaks produced from all three metabolites were non-overlapping (including with 
unknown peaks in fermentation), and distinct from each other. 
  
 
2.5.2 Glycerol calorimetric detection  
Quantification of glycerol in the samples was done using glycerol calorimetric detection 
reagent purchased from Sigma-Aldrich (Sydney, Australia). This reagent measures 
glycerol by using enzymatic reaction: 
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Glycerol is phosphorylated to glycerol-3-phosphate by glycerol kinase, followed by 
oxidation reaction by the glycerol phosphate oxidase. The resultant hydrogen peroxide 
is catalysed by peroxidase to produce a brilliant purple colour that can be detected by an 
absorbance at 540 nm. 
The reagent can be stored at 4°C away from light for a few months after dilution with 
miliQ water, provided that no change of colour (pale yellow) or cloudy solution is 
formed. The reagent must also be equilibrated to room temperature before the assay.  
There is no general amount of the reagent that needs to be added to the samples, as long 
as sufficient colour is developed to be detected by spectrophotometer. In our case, 90 
µL of reagent solution is added to 10 µL of samples or standards in a 96-well plate. The 
plate is gently shaken for a few seconds to mix and left for 15 minutes at room 
temperature to react. As the detection is very sensitive, the acceptable range of glycerol 
concentration is around 20 mg/L. The plate was read using a microplate reader (Biorad 
Model 680) at 450 nm.  
  
 
2.5.3 Inductively coupled plasma mass spectrometry (ICP) 
Quantification of heavy metals was performed using Varian inductively coupled plasma 
mass spectrometry (ICP-OES Model 720) using the mixture of heavy metal standards 
(Sigma-Aldrich). All the elements that were tested are depicted in appendices. The 
samples were filtered through 0.22 µm filter before application. Minimum of 5 mL is 
required for each sample injection with a typical concentration of 5, 10 and 20 parts per 
million (ppm). 
2.5.4 Carbohydrate determination 
Carbohydrate concentration in this experiment was determined using another 
calorimetric method, which is phenol-sulfuric acid assay [70]. Both phenol and 
concentrated sulphuric acid were obtained from Sigma-Aldrich (Sydney, Australia). 
When carbohydrates are treated using strong acids, they will be converted into furfural 
and its homolog by oxidation, reduction and condensation processes. These compounds 
will then react with organic compounds such as phenol to form specific colours.  
Similar to glycerol detection, there is no general rule on how much sample of reagent 
needed, as long as the colour developed is enough to be detected by spectrophotometer. 
In our case, using a 96-well plate, 50 µL of the sample was rapidly added to 150 µL of 
concentrated sulphuric acid, followed by 30 µL of 5% phenol. The mixture was then 
incubated for 10 minutes 90°C in the incubator. Finally, the colour change was 
measured using a microplate reader (Biorad Model 680) at 490 nm.  
  
  
 
2.6 Characterisation of metabolic expression profiles using RT-PCR 
2.6.1 Isolation of total cellular RNA 
Prior to the extraction, the fungus pellet was freeze-dried using Alpha 1-2 LDplus freeze 
dryer (Fisher Bioblock Scientific, Germany) to obtain a fine powder form as part of the 
fungus homogenisation process of the fungus. The extraction of fungal isolates was 
performed using ISOLATE II RNA Plant Kit purchased from Bioline (Sydney, 
Australia). To assist in the cell lysis, 350 µL of Lysis Buffer RLY and 3.5 µL β-ME was 
added to 100 mg of fungal sample and sample was vortex vigorously. Later, the mixture 
of the reagents and samples were filtered using the specific filter provided with spinning 
the tube for 1 minute at 11000g. The filtrate was transferred to a clean, sterile tube, and 
350 µL of 70% ethanol was added to the filtrate by pipetting up and down for a few 
times. The filtrate then was trapped in a special filter provided with the kit by 
centrifuging the filtrate for 30 seconds. The resultant lysate was discarded. The filter 
that contains the RNA transcripts was then transferred into a new tube, and 350 µL of 
Membrane Desalting Buffer was added on top of it. The filter was then centrifuged at 
11000g for 1 minute to dry the membrane. To digest unwanted DNA, 95 µL of DNase I 
enzyme was added directly onto the center of silica membrane, and was left at room 
temperature for 15 minutes. The silica membrane was then washed by using Wash 
Buffer RW1 and RW2 before transferring into fresh nuclease-free 1.5 mL collection 
tube. Finally, the RNA can be collected by adding 60 µL RNase-free water on top the 
membrane, followed by centrifugation at 11000g for 1 minute.  The concentration of the 
isolated RNA was measured using a NanoPhotometer (Implen GmbH, Munich, 
Germany). Samples were stored at -80°C until use. 
  
 
2.6.2 Synthesis of complementary DNA (cDNA) from RNA 
Complementary DNA (cDNA) was prepared following total RNA isolation using Tetro 
cDNA Synthesis Kit (Bioline, Sydney. Australia). All the solutions were briefly vortex 
and centrifuged before use. The priming premix should be prepared in RNase-free 
reaction tube on ice using the guideline of Table 2.1: 
Reagents Volume 
Total RNA (up to 5 µg) 5 µL 
Primer Oligo dT 1 µL 
10 mM dNTP mix 1 µL 
5x RT buffer 4 µL 
Ribosafe RNase inhibitor 1 µL 
Tetro reverse transcriptase 1 µL 
DEPC treated water 7 µL 
Table 2.1: The combination of sample and reagents for the synthesis of cDNA. 
The samples were then placed into a Biorad T100 Gradient Thermal Cycler (NSW, 
Australia). The RT program consisted of incubation at 45 °C for 30 minutes, the 
termination reaction at 85°C for 5 minutes, before being cooled briefly on ice for a few 
minutes. A no RNA RT sample was prepared for each experiment, where DEPC.H2O 
was substituted for RNA, to act as a negative control for the RT-PCR procedure. 
Immediately following the reverse transcription, cDNA was diluted 1 in 5 by the 
addition of 80µL of DEPC.H2O and then stored at -80°C until use. Analysis of the 
integrity of products was performed by running 10 µL PCR product with 2 µL 10X blue 
juice gel loading buffer (Life Technologies) on 1% agarose gel for 30 minutes at 75 
  
 
volts. The products were visualised using ethidium bromide under UV light. The size of 
the PCR products was determined according to the molecular ladder (Bioline, Sydney, 
Australia).   
2.6.3 Real-time polymerase chain reaction (RT-PCR) for quantification of lovB 
levels 
The expression of the gene of interest was analysed using the SYBR green method of 
detection. Amplification of cDNA was performed using 1 µL of 1 in 5 diluted cDNA, 
0.8 µL of both forward and reverse primer (determined following primer optimisation, 
shown in Appendix), 4 µL of cDNA was combined with 10 µL of 2x SensiFast SYBR 
No-Rox One-Step Mix, 0.2 µL reverse transcriptase, 0.4 µL RiboSafe RNase Inhibitor 
and 3.8 µL of DEPC-treated water to the final volume of 20 µL, as depicted in Table 
2.2. Each sample was prepared in triplicate, and the no RNA RT was used as a negative 
control to ensure no nucleic acid contamination was present in any reagents used 
through the procedures.  
  
  
 
Reagent Volume 
2x SensiFast SYBR No-Rox 
One-Step Mix 
10 µL 
10 µM Forward primer 0.8 µL 
10 µM Reverse primer 0.8 µL 
Reverse transcriptase 0.2 µL 
RiboSafe RNase Inhibitor 0.4 µL 
DEPC-treated water 3.8 µL 
Template (cDNA) 4 µL 
Total 20 µL 
Table 2.2: The amount of each reagent used in RT-PCR.  
Samples were cycled in the Rotor-Gene 6000 and analysed using Rotor-Gene 
Series 1.7 software. The PCR procedure consisted of incubation at 45C for 10 minutes, 
95C for 2 minutes followed by 40 cycles of 95°C for 5 seconds (denaturing), 60°C for 
10 seconds (annealing) and 72°C for 5 seconds (elongation). Fluorescence readings 
were recorded on the SYBR channel on the completion of each 72C cycle. Specificity 
of amplification was confirmed by the generation of a melt curve following each PCR 
procedure, where a single amplification peak indicated a single PCR product (in 
appendix). Details of the primers utilised in this study are listed in Appendices. All 
primers were purchased from Sigma-Aldrich (Sydney, Australia). The endogenous 
reference gene β-actin was used to normalize cycle threshold (Ct) data obtained from 
the genes investigated. The relative expression of the target genes in the studied samples 
was obtained using the difference in the comparative Ct (Ct) method. For each sample, 
a value for threshold (Ct) was determined, defined as the mean cycle at which the 
  
 
fluorescence curve reached an arbitrary threshold. The Ct for each sample was then 
calculated according to the formula Ct target gene - Ct β-actin. Finally, relative levels of 
expression of the target genes in the studied samples as compared with the reference 
sample were calculated as 2
-Ct
. 
  
  
 
2.7 Microscopy 
For the general characterisation of the pellet morphology, the images of the fungus 
pellet were taken by using Digital Blue QX7 Computer Optical Microscope (Digital 
Blue, Atlanta, USA).  
For the detailed viewing of much smaller fungus spore, Scanning Electron Microscope 
(SEM) was used (Hitachi S4500 FEG-SEM). Before the SEM was used, the samples 
were prepared and mounted on the special thermanox coverslip (ProSciTech, QLD, 
Australia). The coverslip was treated with a special cell-adhering solution (1% 
polyethylenimine) to ensure the spores will stick to its surface. The coverslips were 
briefly rinse with 90% acetone, followed by a wash with Milli-Q water before being 
incubated at least for 60 minutes in 1% PEI solution. The coverslips then were rinsed 
twice with Milli-Q water and dried in the oven at 60 C for 10 minutes.  
When the coverslips are ready, the spores were adhered to its surface by adding 
sufficient liquid spore solution on the coated side of the coverslips. After 30 minutes of 
incubation, the spore’s solution can be discarded, and primary fixative (2.5% 
glutaraldehyde) was added for at least 1 hour. After the primary fixative was discarded, 
secondary fixative (1% osmium tetroxide in 0.1M PBS) was added and incubated for 1 
hour. The specimen coverslips were washed three times with Milli-Q water for five 
minutes each before the procedure of dehydration series can be performed. 
The dehydration steps involved several washing procedures using increasing 
concentration of ethanol to remove the trace of water in the sample. In short, the 
washing involved the immersion of coverslips in different ethanol concentration (30%, 
50%, 70%, 95% and 100%), for 30 minutes each. The coverslips then were treated with 
  
 
an hexamethyldisilazane (HDMS) solution for two minutes and the samples were put in 
a desiccator with the lid off to allow the HDMS fumes to evaporate overnight. Finally, 
the coverslips can be mounted on stubs and coated with gold for viewing.   
2.8 Statistical analysis 
All experiments were conducted in a minimum of triplicates, except for the bioreactor 
study. Data obtained for metabolite production involving lovastatin, (+)-geodin and 
sulochrin were analysed using one-way ANOVA with Tukey post hoc test. The results 
are considered significant when p<0.05. All statistical analysis was performed using 
GraphPad Prism, version 6.01. For the plotting of the graph, 95% confidence interval 
was used for the error bar.  
 
  
  
 
Chapter 3 - Optimisation of media condition 
3.0 Introduction 
Optimal production of metabolites by fungi or any microbes is dependent on the 
composition of culture media. A standard medium for the cultivation of A. terreus 
ATCC 20542 has not yet been described. However, the medium is normally comprised 
of carbon source (s), nitrogen source (s), water, salts and micronutrients (as discussed in 
the introduction section).  
It is generally accepted that a nitrogen-deficient culture medium favours the growth and 
metabolite production of A. terreus. The majority of studies suggest that complex 
nitrogen sources arebetter for the growth of A. terreus [34,37,49,51,53]. It was 
suggested that these complex nitrogen sources are only utilised by fungi because of the 
lack of ammonium ion [43]. However, in another study, the use of nitrates and 
ammonium as nitrogen source failed to produce any lovastatin [37]. Therefore, this 
study aimed to determine the optimal nitrogen sources, both for growth and metabolite 
production of the A. terreus. 
By contrast, the most suitable carbon source for optimal metabolite production varies in 
the literature and is largely dependent on the cultivation method. For example, some 
studies reported that slowly-metabolised carbons are better for metabolite production 
[37,49,54]. However, a few other studies showed a good metabolite production using 
fast-metabolised carbons, such as fructose and glucose [50,51]. We hypothesised that 
the rate of carbon being metabolised does not affect the production of metabolites. In 
this study, a range of carbon sources were used to determine whether the production of 
metabolites is dependent on the rate of carbon consumption.  
  
 
The optimisation of basal salt condition and its possible physiological effect on the 
fungal pellet will also be investigated. The effect of salt can be either ion-specific [55] 
or osmotic-based [71]. As there are multiple basal salt formulae in the literature, an 
optimal salt medium (in relative to the type of carbon and nitrogen used in this 
experiment) will be investigated, and subsequently be used in all the incoming 
investigations.  
The pre-culture condition may also influence microbial growth and metabolite 
production. According to Bizukojc et al. (2009), pre-culture for A. terreus is important 
to speed up the stationary phase into metabolite production phase [60]. During pre-
culture, an optimal ratio of nitrogen and carbon is required; and this may differ from the 
main culture medium. The optimal spore conditions, such as spore age and spore 
amount, are also essential for the pre-culture to thrive [35].  
This chapter aimed to investigate the effects of different carbon and nitrogen sources, 
carbon/nitrogen ratio, salt types and pre-culture conditions on the production of 
lovastatin, (+)-geodin and sulochrin. At the same time, the morphology of the fungus 
was also analysed. The data from this chapter was used as a basis for the proceeding 
chapter: Cultivation of A. terreus in Crude Glycerol. 
  
  
 
3.1 The effect of salts interactions on the production of lovastatin 
Salt is an essential component of the culture media. Besides providing additional 
nutrients in the form of the metal ions, it is also essential for the regulation of osmotic 
pressure in a microorganism. In our investigation, we tried to minimise the use of salt as 
a means to limit the interaction of salts with the fungal strain, therefore reducing the 
false-positive results. The use of the salts in this experiment is depicted in Table 3.1 and 
were pre-determined by referring to the previous literature [55,72,73].  
MnSO4 ·5H2O, CuSO4·5H2O and FeCl3·6H2O formed crystal deposits in the solution 
when all the salts were combined and heated together in an autoclave at 121°C for 15 
minutes under high pressure. Their exclusion from the media was shown to improve 
lovastatin production by more than two-fold. The addition of CaCl2·2H2O in the media 
produced no significant change in lovastatin production; hence it was also excluded 
(Table 3.1). Other salts, such as KH2PO4, MgSO4•7H2O, NaCl and ZnSO4•7H2O were 
shown to be important as their absence would reduce lovastatin production (Table 3.1). 
No-salt negative control showed a considerable reduction of lovastatin production 
compared to the highest lovastatin produced (17.5% lower). In all the experiments 
performed, the biomass did not differ significantly between different treatments.  
Based on these initial results, we optimised the amount of KH2PO4, MgSO4•7H2O and 
NaCl using a full factorial design (3 levels), as depicted in Table 3.2. As shown in Table 
3.2, the optimal amount of KH2PO4 and NaCl is 0.4 g/L, and MgSO4•7H2O is at 0.2 g/L. 
  
  
 
 
Table 3.1: Optimisation experiment of salt contents in the media. Black-shaded cells 
indicate exclusion of salt from the solution. Lovastatin amount was measured at day 5. 
All treatments showed statistically significant increase in lovastatin production when 
compared to treatment 1 (positive control). Only treatment 2 and 3 are statistically 
significant when compared to treatment 8 (negative control).  
  
Salts Amount 
(g/L) 
Treatments 
1 2 3 4 5 6 7 8 
KH2PO4 1.0         
MgSO4·7H2O 0.8         
NaCl 0.8         
ZnSO4·7H2O 0.001         
CaCl2·2H2O 0.1         
FeCl3·6H2O 0.08         
CuSO4·5H2O 0.01         
MnSO4 · 5H2O 0.001         
Lovastatin (mg/L)  3.10 11.85 10.59 9.58 8.42 8.57 8.18 7.12 
Biomass (g/L)  7.86 7.79 8.01 7.86 7.67 7.63 7.85 7.55 
  
 
Set KH2PO4 (mg/L) MgSO4•7H2O (mg/L) NaCl (mg/L) Lovastatin (mg/L) 
1 0.4 0.2 0.1 7.84 ± 1.05 
2 0.1 0.1 0.1 6.15 ± 0.45 
3 0.1 0.4 0.2 6.04 ± 0.87 
4 0.1 0.2 0.2 7.67 ± 0.94 
5 0.1 0.1 0.4 7.55 ± 1.34 
6 0.4 0.1 0.1 7.32 ± 1.15 
7 0.2 0.2 0.2 7.75 ± 0.73 
8 0.2 0.2 0.4 7.91 ± 1.36 
9 0.4 0.2 0.2 7.96 ± 1.01 
10 0.2 0.4 0.1 6.32 ± 0.66 
11 0.2 0.1 0.4 7.18 ± 0.69 
12 0.1 0.1 0.2 6.25 ± 1.12 
13 0.4 0.4 0.1 6.68 ± 0.83 
14 0.4 0.1 0.4 9.05 ± 1.47 
15 0.2 0.4 0.2 6.91 ± 0.79 
16 0.2 0.1 0.1 7.17 ± 1.25 
17 0.1 0.4 0.4 6.67 ± 0.94 
18 0.1 0.2 0.4 7.62 ± 1.38 
19 0.4 0.4 0.2 6.59 ± 0.53 
20 0.4 0.2 0.4 9.96 ± 1.63 
21 0.4 0.1 0.2 7.27 ± 1.14 
22 0.4 0.4 0.4 7.56 ± 0.87 
23 0.1 0.4 0.1 6.05 ± 0.48 
24 0.2 0.4 0.4 7.39 ± 1.04 
25 0.2 0.2 0.1 7.34 ± 1.07 
26 0.1 0.2 0.1 6.13 ± 0.91 
27 0.2 0.1 0.2 7.03 ± 0.79 
 
Table 3.2: Optimization of the amount of three chosen salts (KH2PO4, 
MgSO4•7H2O and NaCl) on lovastatin production, using 3-level factorial design). 
95% confidence was used as the standard error. 
  
 
3.2 Nitrogen sources 
As previously discussed in the introduction section, nitrogen source is one of the major 
components in the fermentation media, and complex nitrogen sources are usually 
preferred in the cultivation of A. terreus [34,37,49]. 
In this investigation, this theory was revisited and tested using selected nitrogen sources 
at 4 g/L each, according to Bizukojc et al. recommendation [53]. We opted to use 
ammonium sulphate (AS), as a simple and an easily reproducible nitrogen source; and 
several complex nitrogen sources, namely powdered soybean (SB), yeast extract (YE) 
and flour. Figure 3.1 summarises the production of lovastatin, (+)-geodin and sulochrin 
by A. terreus under the influence of different nitrogen sources over the period of 12 
days. From our findings, it is clear that the use of AS is not favourable for metabolite 
production, as significant reduction was observed across all three metabolites tested. 
This reduction was also observed by Hajjaj et al. [37], who observed no lovastatin 
production when ammonium ion was used as the main nitrogen source. However, they 
also observed that A. terreus primarily utilised ammonium ion for growth, which was 
the opposite with our finding. We found that the cultivation of A. terreus in AS 
produced significantly smaller and lighter pellet, with a soft, jelly-like appearance as 
compared to other nitrogen sources. This result indicates that apart from inhibiting 
metabolite production, the application of ammonium ion is also unsuitable for the 
growth of A. terreus. So far, the main reason why this happened is still unknown, as 
most microorganisms can readily assimilate ammonium ion for their growth. However, 
upon further investigation, it was observed that the use of ammonium ion acidifies the 
media (pH 4.1), which might be not conducive for A. terreus. It is possible that the 
application of simple nitrogen sources that do not acidify the media would result in 
better metabolite production. 
  
 
The use of complex nitrogen sources showed better production of lovastatin, (+)-geodin 
and sulochrin, without acidification of the media (all produced pH>6). While the 
production of lovastatin showed significant improvement, a larger spike in production 
can be observed in (+)-geodin and sulochrin. The pattern of production of (+)-geodin 
and sulochrin was also highly similar (as they are also being produced in the same 
pathway), which may indicate that their production is influenced by the same factor. SB 
was shown to be the best nitrogen sources for both metabolites, followed by YE and 
flour. Although the main reason is unclear, Bizukojc M. et al. (2011) proposed that (+)-
geodin’s production is reduced in the presence of nitrogen [74]. It is possible that SB is 
utilised more rapidly than the other nitrogen sources, which leads to the increase of (+)-
geodin and sulochrin in the broth. Further analysis of nitrogen consumption profile 
would be beneficial for the confirmation of the theory.   
  
 
 
Figure 3.1: Lovastatin, (+)-geodin, and sulochrin production over the period of 12 
days. Lovastatin, (+)-geodin and sulochrin production of ammonium sulphate (AS) 
were significantly lower than other nitrogen sources. A) Lovastatin production levelled 
off after day 4 in all treatments. B) Reduction of (+)-geodin’s production was observed 
only after day 8, while in C) sulochrin’s production was still continuing even after day 
12. Symbols show experimental values while dashed lines connecting symbols are used 
as a visual guide only.   
  
 
3.3 Pre-culture 
Pre-culture is a preliminary culture that prepares the microorganisms for production 
culture. Pre-culture for A. terreus is essential to provide sufficient nutrients and shorten 
the time of cultivation. In this section, we tested the effect of pre-culture and the optimal 
concentration of nitrogen sources (yeast extract) needed for the pre-culture. The amount 
of carbon (lactose) for all the treatments was constant at 10 g/L (with 8 g/L YE), except 
for the control at 20 g/L (with 4 g/L YE). After 24 hours, the fungal pellet was 
transferred into culture media (20 g/L lactose and 4 g/L YE) for 5 days to measure its 
effect on lovastatin production. The summary of the experiment and results are shown 
in Table 3.3.  
In our investigation, the optimal YE (as nitrogen source) for pre-treatment was at 8 g/L 
as it produced high amount of lovastatin (12.33 mg/L), although it did not produce the 
highest biomass or the diameter of the fungal pellet. In a previous investigation, it has 
been found that biomass growth of A. terreus is not directly related to lovastatin 
production [53]. Similarly, the bigger pellet diameter may also reduce its production 
[43]. However, this relationship was not investigated further.  The usage of 4 g/L YE 
showed significantly lower growth and smaller pellet, which translated into lower 
lovastatin production (7.96 mg/L). In contrast, the usage of 12 g/L of YE produced 
significantly larger pellet and larger biomass, with low lovastatin production.  
  
  
 
Treatment Biomass 
(g/L) 
Lovastatin 
(mg/L) 
Diameter 
(mm) 
0 g/L YE 1.69 3.19 0.40 
4 g/L YE 6.18 7.96 1.11 
8 g/L YE 7.51 12.33 2.05 
12 g/L YE 10.83 9.12 2.51 
Control 5.10 6.54 1.46 
 
Table 3.3: The effect of nitrogen source (yeast extract) concentration on growth, 
metabolite production, and diameter of A. terreus. Control experiment consisted of 
higher carbon source (lactose) at 20 g/L. The production of lovastatin and biomass were 
significantly different between treatments. The diameter was taken 24 hours after 
cultivation while biomass and lovastatin were measured at the end of 5-days cultivation 
Spore factor, which is another key feature in pre-culture media, was investigated next. 
As mentioned in the introduction, there were three different hypotheses on the 
formation of the pellet from spores. Figure 3.2 from scanning electron microscope 
suggests that it is likely that the formation of pellet arises from the aggregate of multiple 
spores. The main factors studied in this work were the spore amount and age, as shown 
in Figure 3.3. The importance of spore factors had been demonstrated numerous times 
in other studies [43,75]. Our observations showed that while spore amount affected the 
production of all three metabolites, the difference in production was only significant 
when the spore amount was increased from 10
5
 to 10
7
 spore/L, but not from 10
7
 to 10
9
 
  
 
spores/L.  It could be that high spore amount would reduce the pellet diameter, which 
contributed to the higher lovastatin production, which was also observed in another 
study [43]. It is currently unknown why (+)-geodin and sulochrin reacted negatively to 
the increase of spore amount. It is most likely that higher spore would reduce the 
oxygen content in the media, which is essential for the formation of these metabolites. 
Therefore, 10
7
 spores/L was chosen as the spore amount to be used in the future 
experiments, as the adequate production of lovastatin, (+)-geodin and sulochrin was 
observed at this particular spore amount. 10
9
 spores/L was not chosen as it produced 
very high biomass, which increases the complexity of transferring the fungus pellet into 
new cultivation media, coupled with low production of (+)-geodin and sulochrin.  
A similar conclusion can be made involving spore age. Spore age is measured based on 
how long the fungus was grown on the solid media i.e. PDA plate before harvested into 
suspension. Higher spore age produces higher metabolites but was not significant in 
value from one point to the other. A significant change in metabolite production was 
observed only when the concentration of spores was increased from 10
5
 to 10
9
 spores/L 
(two-point increase). This is supported by images taken from an electron microscope, 
which found no difference in term of spore morphology at day 5, 7 and 9 (Figure 3.4). 
Considering 7 days of culture is more feasible in term of experimental design, this time 
point was chosen for all the experiments.  
  
  
 
 
Figure 3.2: The scanning electron microscope image of A. terreus spores under 5000 
times magnification. An aggregate of spores was observed after 4 hours post-
inoculation, which suggests that the rise of the single pellet is resulted from the 
combination of multiple spores. 
 
  
 
 
Figure 3.3: The investigation of spore factors on the production of metabolites by A. 
terreus. A) Non-significant change of metabolite production was observed when  
different spore amount was used. B) Increasing spore age also had minimal 
improvement on metabolite production. 
  
 
 
Figure 3.4: The example of scanning electron microscope image of A. terreus spore 
taken from the spore stock under 15000 times magnification. No differences in size 
or morphology were observed at A) 5 days B) 7 days and C) 9 days.  
 
  
  
 
3.4 Carbon source 
3.4.1 The relationship between lovastatin, biomass and morphology production of 
A. terreus under different carbohydrate treatments 
 
The present study investigated the effects of different sources of carbon in the form of 
carbohydrates, comprising of monosaccharides (D-glucose, D-xylose, D-fructose, D-
galactose, D-mannose, D-ribose, D-arabinose) and disaccharides (α-lactose, maltose, D-
sucrose), on the cultivation of A. terreus (Figure 3.5).  
Morphology of fungus is one of the key factors that influence the production of 
metabolites. The submerged pellet form is known to produce a higher production of  
lovastatin when compared to filamentous fungus [33,34]. Therefore the pellets were 
used for the experiment. The experiment involving different carbohydrates began with 
the pre-culture media. Figure 3.6 showed little differences in fungus morphology in the 
presence of different carbohydrates in the pre-culture media. It is most likely that the 
immature form of the fungus would not exhibit any morphological differences, as a 
means of maximising nutrient uptake through the filament. This highly filamentous 
pellet structure persisted even until 24 hours when a visible pellet has already formed. 
Spherical, round pellets with different hair characteristics can only be observed after 48 
hours of culture. Figure 3.7 shows the three main pellet morphologies observed 
following treatments after the end of cultivation, which served as our point of reference 
throughout the discussion. 
 
 
 
  
 
 
 
Figure 3.5: Different structures of monosaccharides and disaccharides used in this 
study. Carbohydrate structures have been shown to influence how carbon is taken and 
metabolised by several microorganisms [76,77]. From top left: A) D-glucose B) D-
mannose C) D-galactose D) D-ribose E) D-fructose F) D-arabinose G) D-xylose H) α-
lactose I) D-maltose J) D-sucrose. In K), the structure is glycerol, which will be used as 
a control in this experiment. 
  
  
 
 
Figure 3.6: The electron microscopy images of spore cultivated in different 
carbohydrates after 24 hours. Only a mass of highly filamentous hair clump was 
observed across all treatments without any distinguishing features. A) Glucose, B) 
galactose, C) lactose, D) maltose, E) mannose, F) ribose, G) xylose and F) fructose.  
  
  
 
 
 
Figure 3.7: Three major pellet morphologies observed during fermentation of A. 
terreus at day 6. In A) – hairless (e.g. D-glucose-treated), B) short-haired (e.g. D-
fructose-treated) and C) long-haired (e.g. D-arabinose-treated). Hairless pellets were 
more dense (or heavier) with a lower tendency to clump. Short-haired pellets have a 
loose feature with a higher tendency to clump, and exhibit patchy hair growth. Long-
haired pellets generally have thick filamentous hair; and hollow, porous pellet.  
  
  
 
Table 3.4 and Figure 3.8 show the yield coefficient (YLOV/S) of carbohydrates, final 
biomass (XFINAL) of pellet, final diameter (ØFINAL) of pellet, final pH and lovastatin 
production of A. terreus. We observed that the production of lovastatin is mainly mixed-
growth associated with all the substrate tested, as lovastatin was detected in the early 
and late phase of biomass production. This mixed-growth pattern was also observed by 
Bizukojc et al., in the presence of α-lactose [53]. Low yield coefficients within 
monosaccharides group were detected in D-galactose (YLOV/S = 1.02), D-arabinose 
(YLOV/S = 0.66) and D-glucose (YLOV/S = 0.96); while the highest was observed in D-
xylose (YLOV/S = 3.49) and D-fructose (YLOV/S = 3.11). Disaccharides, in general, gave a 
satisfactory production of lovastatin (YLOV/S = 2.01 - 2.94), with sucrose giving the 
highest yield coefficient (YLOV/S = 2.94).   
Slowly-metabolised carbon, particularly α-lactose (YLOV/X = 4.47) and glycerol (YLOV/X 
= 9.69), have been described as the optimal carbon source for lovastatin production 
[35,49]. However, our findings show that there are other carbohydrate substrates with 
higher efficiency for lovastatin production by A. terreus such as D-xylose (YLOV/X = 
9.69) and D-fructose (YLOV/X = 8.68). Unlike some organisms [78,79], we observed that 
the group or structure of sugars (mono- and disaccharides, or pentoses and hexoses, or 
pyranose or furanose) have no effects on the production of biomass and lovastatin. The 
details of the parameters given in Table 3.4 and Figure 3.8 would be further discussed in 
the subsequent paragraphs.  
 
 
  
  
 
 
    Carbohydrates YLOV/S 
(mg/g/L) 
YLOV/X 
(mg/g) 
XFINAL 
(g/L) 
ØFINAL 
(mm) 
Final pH 
Monosaccharides      
D-arabinose 0.66 1.19 7.28 1.56 7.06 
D-galactose 1.02 1.68 8.64 2.32 7.19 
D-glucose 0.96 3.30 8.02 2.51 7.16 
D-mannose 1.55 5.20 7.28 1.82 6.25 
D-ribose 2.42 6.56 8.74 2.52 7.46 
D-fructose 3.11 8.68 8.78 2.50 7.01 
D-xylose 3.49 9.69 9.24 2.29 6.89 
Disaccharides      
D-sucrose 2.94 7.15 9.14 2.31 6.43 
D-maltose 2.08 6.06 8.08 2.45 6.91 
α-lactose 2.01 4.47 9.44 2.67 6.87 
Control      
Glycerol 1.74 3.46 10.44 2.61 6.88 
Table 3.4: The yield coefficients, final biomass (XFINAL) and final diameter (ØFINAL) 
of A. terreus in the basic media for the period of 6 days.  
 
  
 
 
Figure 3.8: Lovastatin and biomass production under different carbohydrate 
treatment over the span of 6 days using 4 g/L yeast extract as a nitrogen source. 
The production of lovastatin can be grouped into low, medium and high. Biomass 
productions were generally unaffected across different substrates. Error bars represent 
95% confidence interval.  
 
  
  
 
Based on the lovastatin production, these carbohydrates can be characterised into three 
groups: low (5 – 11 mg/L), medium (17 – 32 mg/L) and high (43 – 57 mg/L) lovastatin 
production. Low lovastatin production in this experiment is defined by being 
significantly lower than control (glycerol), medium lovastatin production is similar to 
the control, and high lovastatin production is defined by being significantly higher than 
control. The statistical analysis used was described in Section 2.8: Statistical Analysis. 
The carbohydrates with high lovastatin production (>40 mg/L), namely D-xylose, D-
fructose, D-ribose, and D-sucrose exhibited similar features throughout the 
investigation. All of these substrates increased lovastatin production significantly 
(>37%%) during stationary phase (day 4) compared to growth period (day 2). In 
addition, there are also other common features such as having a short-haired pellet 
morphology; a moderately high final biomass (Xfinal) (8.74-9.24 g/L) and final diameter 
(ØFINAL) (2.31 – 2.52 mm), and pH approaching 7 (refer to Table 3.4). Previous research 
has shown that short-haired pellets [34] and moderate ØFINAL around 2-3 mm [32–34] 
have been associated with optimal lovastatin production, and were thought to be due to 
the balance between growth and oxygen transfer. In contrast, smaller pellets are lacking 
in both filament zone (lovastatin producing) and core region (oxygen containing). 
Similarly, large pellets would reduce the nutrients and oxygen penetration into the 
middle of the pellet, which would cause necrosis and hollow pellet [44].Carbohydrates 
with medium lovastatin production (17 – 32 mg/L), namely D-glucose, α-lactose, D-
maltose, D-mannose and glycerol, exhibited unique pellet morphologies when 
compared to those with high lovastatin production. Of note, we noticed that the pellets 
exhibited hairless morphology in the presence of D-glucose, D-maltose, and α-lactose 
(Figure 3.7A), all of which corresponded with lower lovastatin production. Glycerol 
(control experiment), on the other hand, had almost identical features to the high yield-
  
 
producing carbohydrates including morphology, pH and ØFINAL. Only its XFINAL (10.44) 
is very high which indicates high growth.. While biomass production is also important 
for the viability of fungus, excessive biomass increase may suggest that the metabolic 
route was shifted towards fatty acids biosynthetic pathway. This may adversely affect 
the production of lovastatin due to competition for carbon that serves as precursors 
(refer to Figure 3.10 for metabolite production pathway). Due the complexity of the 
reaction (refer Figure 3.11), there is a possibility that the available carbon source will be 
redirected to other pathways rather than the metabolite production, In contrast, low 
XFINAL, as observed under D-maltose and D-mannose treatment, may also reduce 
lovastatin production due to lack of necessary growth for metabolite production.  
In the low production group (D-galactose and D-arabinose), D-galactose treatment 
exhibited an unfavourable hairless morphology similar to the medium production group. 
Also, the biomass increase (Table 3.4) indicated that D-galactose was probably 
redirected to growth, rather than the metabolite production, similar to glycerol. 
Incomplete D-galactose uptake was also observed (Figure 3.9), most likely due to the 
lack of galactose utilisation pathway in A. terreus [80]. In contrast, we observed pellets 
with long hair feature, displaying gelatinous-like morphology in D-arabinose (Figure 
3.7c), which corresponded with lowest XFINAL and ØFINAL. This is consistent with 
previous reports showing that long hair, highly filamentous morphology is unfavourable 
as this may reduce the nutrient transfer ability [81]. Furthermore, the formation of 
highly filamentous pellet reduces the formation of pellet or core body, which is essential 
for lovastatin formation. This is shown in Figure 3.7C, and also based on its XFINAL 
(which was the lowest, as pellet body contributed to most of its weight). Other possible 
explanation on the effect of different carbohydrates on lovastatin production is shown in 
Table 3.5. 
  
 
 
Figure 3.9: The consumption and consumption rate of carbon sources by A. terreus. 
The numbers at the top of the bar graph represent the consumption rate, r. The 
consumption rate was taken at day 2, assuming the fungus was in its most active state 
(trophophase). 
  
  
 
Carbons Lovastatin Possible explanation (s) 
D-
arabinose 
5 – 11 mg/L 
(Low) 
- Uncommon in nature. Low uptake rate (Figure 3.9). 
Not preferred by fungus [82]. 
- Established pathway of arabinose metabolism in the 
fungus is the oxidoreductase pathway, which involves 
L-arabinose and not D-arabinose [83]. 
D-galactose - Uncommon in fungus’ native habitat. Low uptake rate. 
- Lack both galR and galX regulators that control the 
utilisation of D-galactose in A. terreus [80]. 
- The breakdown of galactose into glucose, and 
subsequently through pentose phosphate pathway 
(PPP)  may cause catabolite repression (Figure 3.11).   
D-glucose 
D-maltose 
17 – 32 
mg/L 
(medium) 
- Suppression of lovastatin maybe due to catabolite 
repression [37] through PPP (Figure 3.11). 
Glycerol 
α-lactose 
- Slowly-metabolised (Figure 3.9) and the rate was 
increased consistently up to day 6. Production was 
lower than expected [49,50], probably due to the 
difference in culture condition (Table 3.6). 
- The breakdown of lactose into glucose, and 
subsequently through PPP may cause catabolite 
repression (Figure 3.11).   
D-mannose - Lovastatin production maximises and plateau at day 2, 
which may limit its potential as a carbon source. 
D-xylose 
D-fructose 
D-sucrose 
D-ribose 
>40 mg/L 
(High) 
- Abundantly found in nature, which increase the 
likelihood to be metabolised efficiently by A. terreus.   
- For example, mstA transporter is used in fungus to 
transport certain carbons such as D-xylose into the cell 
[49,84].  
Table 3.5: The possible explanations on the effect of different carbohydrates as 
carbon sources on the production of lovastatin by A. terreus.  
  
 
Carbon source Nitrogen source (lovastatin yield on biomass (mg/g)) Minerals 
 Yeast extract CSL Soybean meal KH2PO4, 
MgSO4.7H2O 
NaCl, 
Na2B4O7, 
MnCl2, 
Na2MoO4, 
CuSO4  
Lactose 29.20 22.66 30.42 
Fructose 25.47 20.08 12.66 
Glycerol 21.80 18.03 11.46 
 Table 3.6: The example of the lovastatin yield (mg/g) obtained using different 
media composition. The combination of different carbon and nitrogen sources affected 
lovastatin yield greatly. The data was extracted from [49]. The effect of starting 
substrate/carbon has been illustrated in Section 1.2.4, Table 1.1. 
  
  
 
 
 
 
 
 
 
 
 
Figure 3.10: Metabolite production pathway by A. terreus ATCC 20542. Note that 
all metabolite production requires Acetyl CoA as its main precursor. Acetyl-Coa and 
Malonyl-CoA act as precursors to all reactions. The channelling of more precursors 
towards one pathway may potentially cause a deprivation of precursors for other 
pathways.  
  
Carbon Source 
Glyceraldehyde-3 
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Pyruvate 
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Figure 3.11: Possible catabolism pathways of several different carbon sources in A. 
terreus. The presence of complex and branching pathways for each carbon catabolism 
may remove available carbon source for metabolite production Adapted from [85].  
  
 
To further confirm the findings, we performed mRNA analysis on each of the fungus 
treated with the different carbohydrates. As stated previously, we chose lovB as our 
gene of interest as lovB is one of the main genes that are responsible for lovastatin 
production, based on the recommendation by Sorrentino F. et al. [86]. Our gene analysis 
showed almost an even expression mRNA transcript of lovB, and in some cases, the 
opposite of what has been observed with lovastatin production (Figure 3.12). For 
example, we observed that maltose produced higher lovastatin than glucose, but its lovB 
mRNA levels suggest an inverse  role between those two. 
 Based on molecular pathway, one could see that the production of lovastatin is not only 
governed by a single gene, but is controlled by a number of different genes (refer to 
Chapter 1: subsection 1.0.2). Different carbohydrates may induce a different set of 
genes, which causes gene expression studies to be very difficult. Unless a complete 
mapping of gene expression is done, it would not be possible to study the effect of a 
single gene factor in the production of lovastatin. Furthermore, the study only measures 
the production of mRNA, which may not necessarily translate into proteins. Therefore, 
additional work looking at the protein expression of of genes of interest may give more 
insight into the production of metabolites of interest.  
  
  
 
 
 
Figure 3.12: The relative lovB mRNA expression under the influence of eight 
carbohydrates. The expression does not correspond to lovastatin production due to the 
presence of multiple genes (e.g. lovA, lovC, lovD and lovF) that govern lovastatin 
production, and possible differences in the translated protein (from mRNA) 
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3.4.3 (+)-geodin and sulochrin production 
Amongst the many secondary metabolites produced by A. terreus, (+)-geodin and 
sulochrin are the two major metabolites that originate from the same pool of precursors 
as lovastatin but are produced via different pathway. Therefore, it is likely that the 
production of these metabolites may compete with each other for the precursors. This 
has been suggested previously for sulochrin [64]. The possibility that these metabolites 
may have a stimulatory effect should not be excluded as another metabolite, 
butyrolactone I, has been shown to stimulate lovastatin production. Therefore, we 
evaluated the production of these co-metabolites in relation to lovastatin production.  
Figure 3.13 shows the amount of (+)-geodin and sulochrin in culture media over 6 days 
of fermentation. We observed that (+)-geodin and sulochrin production was lower than 
lovastatin, and independent of the carbohydrate sources used. A similar observation has 
been reported for (+)-geodin previously [60]. The low yield obtained in this study may 
result from the limited carbon availability towards the end of the stationary stage of 
fungus fermentation. This has been shown previously where (+)-geodin production was 
dependent on the residual carbon at the end of fermentation, by using lactose as the 
substrate in batch fermentation [60].   
Our findings also suggest that (+)-geodin may be prone to degradation, or perhaps re-
used by the fungus in some way, as its production gradually declined over time with 
lactose as a carbon source. This explanation would be further explored in the subsequent 
chapters.  
  
  
 
 
 
 
 
Figure 3.13: Sulochrin and (+)-geodin production under different carbohydrates 
over the span of 6 days in a basic medium with 4 g/L of yeast extract as a nitrogen 
source. Data are means of triplicates and error bars represent 95% confidence interval.  
  
  
 
Although the production of (+)-geodin is very low, some carbohydrates showed a 
noticeable increase. Some carbon sources (D-sucrose, D-arabinose, α-lactose and 
glycerol) showed low, but a sustained (+)-geodin production up to 6 days. Others 
showed only transient to no (+)-geodin production. For instance, no production of (+)-
geodin was observed in D-glucose on day 2 and 4, suggesting that the catabolite 
repression mechanism may be more pronounced in (+)-geodin synthesis rather than 
lovastatin in this case. (+)-geodin was also undetectable in a D-galactose-treated culture 
which corresponded to low lovastatin production, suggesting that this carbohydrate 
source may be unsuitable for the biosynthesis of these metabolites in A. terreus. 
Surprisingly, D-arabinose seemed to have differential effects on metabolites such that 
lovastatin production was repressed but (+)-geodin production was enhanced (2.78 
mg/L, day 6). (+)-geodin was detected in a high amount (Day 6) in D-sucrose (4.42 
mg/L), α-lactose (3.79 mg/L) and glycerol (3.73 mg/L), probably due to their slow-
metabolised feature (refer to Table 3.6 for carbohydrate consumption). This 
corresponded to a greater increase in (+)-geodin production compared to lovastatin, 
suggesting that slowly-metabolised carbon sources are possibly more suitable for (+)-
geodin production as this would provide higher residual carbon towards the end of 
fermentation, which may stimulate (+)-geodin production.  
Sulochrin is another secondary metabolite (octaketide compound) that serves as a 
precursor or intermediate for (+)-geodin and asterric acid synthesis. Compared to (+)-
geodin, the production of sulochrin was more sustained throughout the fermentation. 
Furthermore, sulochrin’s production was greater compared to (+)-geodin under all 
carbohydrate treatments, except for D-arabinose. So far, the reason for this phenomenon 
is still unexplainable without further experiment.  
  
 
We next assessed the relationship between sulochrin and (+)-geodin production. While 
the production of (+)-geodin was undetected in D-xylose, the production of sulochrin 
(10.99 mg/L, day 6) was high. In contrast, D-arabinose produced low sulochrin (1.57 
mg/L, day 6) but higher (+)-geodin production (2.78 mg/L). Sulochrin in glycerol 
(22.35 mg/L, day 6), α-lactose (10.39 mg/L, day 6) and D-fructose (13.48 mg/L, day 6) 
followed a similar trend to what has been previously observed in (+)-geodin’s 
production, while other carbohydrates led to similar (or basal) amounts of sulochrin at 
the end of fermentation. These results indicate that there is no clear trend across all 
carbohydrates to suggest that sulochrin and (+)-geodin production is influenced by the 
same factors. These results reaffirm the complexity of the evolved metabolism of A. 
terreus, and suggest that there are different carbon growth conditions to enhance 
metabolite production of lovastatin, (+)-geodin and sulochrin. 
  
  
 
3.5 Conclusion 
We found that the production (+)-geodin and sulochrin is more responsive to the 
different type of nitrogen sources, while lovastatin is more responsive to the type of 
carbon sources. There was no apparent connection between the production of lovastatin, 
(+)-geodin and sulochrin in this study when different carbon sources were used. The 
only common observation is the production of lovastatin and sulochrin is more constant, 
unlike (+)-geodin which is more erratic. Unlike morphology, the biomass and lovastatin 
production are not likely to be related as initially thought, as low biomass fungal pellet 
still produced an excellent amount of lovastatin, even after they reached the lag phase 
(indicated by the constant biomass weight).  
 
 
  
  
 
Chapter 4 - Cultivation of A. terreus in crude glycerol 
4.0 Introduction 
Based on the previous chapter, glycerol was found to be a good substrate for lovastatin, 
and an even better substrate for (+)-geodin and sulochrin production. Thus, this finding 
was used as a basis to find a suitable bio-waste for the cultivation of A. terreus. The 
present study explores the potential use of crude glycerol (CG) instead of pure glycerol 
(PG), as a feedstock for the production of metabolites by A. terreus ATCC 20542. Little 
is known about the regulation and the physiology of metabolite biosynthesis of 
lovastatin using CG.  
CG was previously considered a valuable by-product derived from biodiesel industry. 
However, the rapid growth of the biodiesel industry resulted in an overproduction of 
CG, leading to its significant devaluation [87]. For example, the price of refined 
glycerol plunged more than 50%, from USD$100 in 2004 to around USD$40 in 2007 
[88]. CG has become a burden, especially for small biodiesel producers, as improper 
disposal is harmful to the environment, and purification processes are not cost-effective 
[89].  
The bioconversion of CG is particularly challenging as biodiesel-derived CG contains a 
significant amount of impurities. CG contents vary widely with the biodiesel 
manufacturer, ranging from 38% to 96% glycerol; with the remaining normally 
comprised of water, MeOH, free fatty acids and salts [90]. MeOH and fatty acids are 
formed during the trans-esterification process; while salt originates from the catalyst 
used in the biodiesel production process. High contents of impurities in CG may inhibit 
the production of metabolites in most microorganisms [68,91,92]. However, some 
  
 
microorganisms that prefer glycerol as a substrate may adapt themselves to use CG. For 
example, microalgae Schizohytrium limacinum [93], yeast Yarrowia lipolytica [94] and 
bacteria Clostridium butyricum [73] can utilise CG for the production of lipids, citric 
acid and 1,3-propanediol respectively. A. terreus is of particular interest, mainly due to 
its fungus characteristics which is known for their ability to withstand different 
contaminants present in CG.   
This study reports the potential of A. terreus to assimilate crude glycerol and produce 
desired secondary metabolites when CG and pure glycerol (PG) are used as the sole 
carbon source. The first series of experiments involved the cultivation of A. terreus with 
varying concentration of crude glycerol to assess the production of lovastatin and (+)-
geodin. Thereafter, the optimum concentration of CG and PG in shake flask was 
cultivated in a bioreactor and used in a further study to assess the effect of impurities on 
the secondary metabolite production, with a particular focus on MeOH, salt and fatty 
acids. Finally, the efficiency of pre-treated CG was evaluated by assessing the growth 
and production of metabolites by A. terreus. The summary of the experimental method 
for impurities in this chapter is shown in Table 4.1. 
  
  
 
 
Impurities Amount present 
in CG (g/L) 
Concentration used 
in media (g/L)  
MeOH 1 
0.25 
0.5 
1 
NaCl 2 
1 
2 
4 
Fatty acids 
Unknown, may 
reach 20  
0.3 
1.5 
3 
Table 4.1: Chemical composition and experimental design of impurities used in this 
study.  To avoid variation in the impurities present in the sample, the same batch of CG 
was used for every experiment. All experiments used basal salt media as described in 
methodology, 30 g/L PG and 4 g/L of yeast extract. Control experiments were untreated 
media. All experiments were conducted in triplicates.  
  
 
4.1 Growth, glycerol consumption and metabolite production  
The ratios of glycerol to yeast extract were fixed at 2.5, 7.5 and 12.5 in all experiments 
by adjusting the amount of CG added to the media (CG contains only 45% of glycerol). 
The biomass profile at day 6 is shown in Figure 4.1. In general, the biomass increased 
with increasing PG and CG concentration. In all cases, the concentration of biomass 
was only slightly higher in the presence of PG compare with CG. This shows that the 
impurities present in CG have minimal effects on A. terreus growth, consistent with 
previous studies which reported the ability of different strains of Aspergillus species 
survive on industrial wastes (excluding CG)  [95,96].  
Figure 4.2 shows the trend of the CG and PG consumption rate by A. terreus as a 
function of cultivation time (days) at different initial substrate concentrations. Rapid 
glycerol consumption was observed in the early stage, followed by reduced uptake rate 
over time in the presence of both substrates, which obey the basic principle of 
microorganism growth curve. This also a possibly indicates a shift in A. terreus growth 
from an exponential phase to a lag phase. There was less consumption of CG compared 
to that of PG, indicating that the quality of glycerol is essential for substrate uptake 
efficiency. The difference in the glycerol consumption was more noticeable at 50 g/L 
where glycerol content in PG was exhausted by day 6 whereas residual glycerol was 
still detectable in CG (~11 g/L). This indicates that the ability of the fungus to utilise 
CG might be impaired as a result of increased toxicity due to inhibitors present in CG.  
 
  
 
 
Figure 4.1: The biomass growth curves of A. terreus in the presence of different 
concentrations of CG and PG. Concentrations of the substrates have a bigger 
influence on biomass growth compared to the type of substrates. Symbols show 
experimental values while dashed lines connecting symbols are used as a visual guide 
only. Error bars show 95% confidence.  
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Figure 4.2: Effect of different concentrations of PG and CG on glycerol 
consumption by A. terreus in 50 mL shake flask experiment. CG reduced glycerol 
consumption at all concentration with 50 g/L CG showed residual glycerol after day 6 
of cultivation. Closed symbols represent PG while open symbols represent CG.  
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It has been established that (+)-geodin is one of the primary co-metabolite of lovastatin 
biosynthesis [22,60]. The production of (+)-geodin is associated with the production of 
sulochrin due to the fact that sulochrin is a precursor for its production [58,59]. Hence, 
it is interesting to study the possible link between their production with that of 
lovastatin and how the production may react to the same factors that affect lovastatin 
production.  
The concentration of metabolites produced, namely lovastatin, (+)-geodin and 
sulochrin, for 6 days cultivation period is shown in Figure 4.3. The use of PG resulted in 
significantly higher lovastatin production than CG at all concentrations of glycerol. The 
production of lovastatin appeared to slow down as glycerol is exhausted, except at 50 
g/L CG, which showed an initial lag phase in lovastatin production at day 2 and 4. The 
production of lovastatin in PG was the highest at 30 g/L,  (CLOV30 = 19.5 g/L; CLOV50 = 
18.9 g/L), which is within the range of a previous report [53]. However, both product 
and biomass yield coefficient was optimal at 10 g/L of PG (YLOV/S = 1.35 mg/g/L, 
YLOV/X = 1.51 mg/g) , compared to 30 g/L (YLOV/S = 0.48 mg/g/L, YLOV/X = 1.49 mg/g) 
and 50 g/L of PG (YLOV/X = 0.28 mg/g/L YLOV/X = 0.28 mg/g). Similarly, 30 g/L CG 
(CLOV30 = 10.1 g/L) was also the highest for lovastatin production, while 50 g/L CG 
(CLOV50 = 3.4 g/L) produced a significantly lower lovastatin production. While the 
pattern of YLOV/S in CG was the same with PG, the YLOV/X was the highest in 30 g/L CG 
(1.1 mg/g), compared to 10 g/L CG (YLOV/X = 0.97 mg/g). This observation indicates 
that the production of lovastatin increased at a higher rate (with respect to biomass) in 
the presence of 10 to 30 g/L of CG, compared to PG.  
The use of CG may negatively influence lovastatin production due to the presence of 
contaminants in CG. Some secondary metabolites are enhanced in the presence of these 
  
 
foreign substances, such as (+)-geodin and sulochrin, as a part of their natural response 
to the stress condition. This indicates that lovastatin may not play an important role in 
this part of the stress response, or simply that certain substance in CG may be inhibitory 
to its production. This hypothesis is explored further in Section 4.2: Effect of impurities.     
In control experiments, lovastatin production has always exceeded (+)-geodin and 
sulochrin, as observed in the presence of PG (Figure 4.3). We also noticed that (+)-
geodin and sulochrin were produced later than lovastatin, and maximised towards the 
end of the cultivation process (Figure 4.3). This indicates that the production of these 
metabolites may be associated with nitrogen deprivation phase  [36,60], which often 
occurs after a few days of cultivation. This observation is supported by the evidence that 
(+)-geodin production is inhibited by the presence of organic nitrogen in the media 
[36,60]. In PG, the concentration of (+)-geodin increased in a dose-dependent manner 
that indicates its production is highly dependent on the amount of initial carbon content 
in the growth media. This is supported by a study conducted by Bizukojc et al. (2007), 
which reported that the initial carbon content has a more pronounced influence on (+)-
geodin production compared to lovastatin [60]. The presence of higher carbon source 
concentration, especially towards the end of cultivation, is important to maintain and 
sustained (+)-geodin’s production [60]. However, compared to PG, the production of 
(+)-geodin and sulochrin were significantly higher in the presence of equal 
concentrations of CG, except at 50 g/L. This observation suggests that (+)-geodin and 
sulochrin is more responsive to an adequate amount of CG, due to the presence of 
inhibitory compounds in CG (further explored in Section 4.2: Effect of impurities). 
However, 50 g/L of CG showed significantly lower (+)-geodin and sulochrin 
production, presumably due to the presence of excessive amount of impurities that may 
negatively affect their metabolite production pathway.  
  
 
 
Figure 4.3. Time course of (A) lovastatin, (B) (+)-geodin and (C) sulochrin 
production by A. terreus in a shake flask experiment using different concentrations 
of PG and CG. In (A), PG produced significantly higher lovastatin than CG at all time 
points. In (B) and (C), both (+)-geodin and sulochrin production were significantly 
higher at 10 and 30 g/L of CG at day 6. A value of p<0.05 is considered significant. 
  
  
 
In terms of morphology, the pellet diameter between these two treatments was roughly 
the same. The more notable change was observed on the surface of the pellet. The use of 
PG produced considerably fluffier pellet while CG produced hairless morphology (refer 
to Chapter 3: Optimisation of basic media condition for further discussion). The 
presence of hair is probably the most obvious indicator that influences the pattern of 
metabolite production, as fluffier and looser pellets have been implicated in higher 
lovastatin production [34]. In terms of (+)-geodin’s production, there has been no study 
yet that examined the relationship between pellet morphology and its production. From 
this result, the production of (+)-geodin and sulochrin seemed to be independent of this 
factor as the increase of these metabolites were observed regardless of the presence of 
hair.   
 
 
 
  
 
  
  
 
4.2 Effect of impurities 
Given that the use of CG as a substrate resulted in different patterns of metabolite 
production compared to PG, additional studies were conducted to investigate whether 
these variations or changes in metabolite production were mainly due to the presence of 
the major impurities in CG, which are MeOH, salt (NaCl) and fatty acids. In this 
experiment, known concentration of impurities (based on the concentration present in 
CG) was added on top of 30 g/L of PG to assess its effect on lovastatin, (+)-geodin and 
sulochrin production by A. terreus.  
4.2.1 Methanol improved lovastatin production but suppress (+)-geodin and 
sulochrin production 
Figure 4.4 shows the production of lovastatin, (+)-geodin and sulochrin using PG as a 
carbon source in the presence of different concentrations of methanol (MeOH) over the 
course of 6 days of cultivation. MeOH addition suppressed the production of (+)-geodin 
and sulochrin at all concentrations while it appeared to significantly stimulate lovastatin 
production. Of note, increasing MeOH concentration to 1 g/L reduced lovastatin 
production at day 4, although it recovered on day 6. This may be related to the reduction 
of glycerol consumption, as only the addition of 1 g/L MeOH reduced the consumption 
of glycerol by almost 13% on day 2. It can be also due to the growth suppression, as the 
pellet diameter was considerably smaller at this concentration compared to when 0.25 
g/L and 0.5 g/L of MeOH was used (Table 4.2). Although the inhibition of biomass was 
also observed, the pattern was not concentration-dependent (Table 4.2), which make it 
unlikely to be the reason. No difference in term of hair growth was observed between 
control (PG) and MeOH this time, as both produced fluffy pellets.   
  
  
 
 
Figure 4.4: Effect of methanol (MeOH) addition to (A) lovastatin production, (B) 
(+)-geodin production and (C) sulochrin production by A. terreus in shake flask 
experiment. In (A), production of lovastatin is significantly higher in MeOH compared 
to NT control at day 6, while its production at 1 g/L of MeOH was shown to be 
significantly lower at day 4. In (B) and (C), all the MeOH-treated media produced 
significantly lower (+)-geodin and sulochrin than NT control at day 6. Significance is 
when p<0.05. 
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Parameters  MeOH initial concentration (g/L)  
 Day 0 (control) 0.25 0.5 1 
Glycerol 
Concentration 
(g/L) 
Day 0 32.9 32.9 32.9 32.9 
Day 2 9.0 8.3 10.7 12.2 
Biomass (g/L) Day 6 9.4 ± 0.23 7.6 ± 0.52 7.3 ± 0.12 7.5 ± 0.52 
Diameter 
(mm) 
Day 6 3.0 ± 0.06 2.4 ± 0.12 2.4 ± 0.06 2.0 ± 0.09 
 
Table 4.2: Growth parameters of fungus in shake flask after six days of cultivation 
of A. terreus in the presence of different initial concentrations of methanol 
(MeOH). 
  
  
 
The stimulatory effect of MeOH on lovastatin production is in agreement with a 
previous study which shows that MeOH influences the transport of molecules in 
microbial cells, mainly through its effects on cell membrane integrity by regulating 
enzymatic and membrane fluidity [97,98]. With the assumption that some of the 
lovastatin resides intracellularly, the changes in cell membrane integrity induced by 
MeOH may allow increased transport of lovastatin into the extracellular media. There 
may be a preferential assimilation of MeOH compared to glycerol, given that MeOH is 
also considered as a type of carbon source [99–101]. Kinetically, MeOH may be 
favoured over glycerol during assimilation, as MeOH can be incorporated into 2 
products, compared to 1 for glycerol. Further, the presence of MeOH may induce the 
MeOH metabolizing genes, whilst the lower production of both (+)-geodin and 
sulochrin may be due to the repression of stress response genes required for the 
production of (+)-geodin and sulochrin [102].  
In terms of a morphological factor, MeOH was implicated to improve the pellet 
morphology by reducing the size of the pellet [98,103], which was also observed in this 
study. Smaller pellet size (Table 4.2) was shown to increase the efficiency of oxygen 
transfer and the total area of the active region inside the fungus that is responsible for its 
metabolite production [43]. Although the pellet size was reduced, this did not interfere 
with the ability of the fungus to grow, as indicated by the stable biomass weight (Table 
4.2). However, high amount of MeOH may reduce the size of the pellet to the point 
where the efficiency of lovastatin production is probably compromised.  
Currently, it is unknown why there is a different response of lovastatin, (+)-geodin and 
sulochrin production, and carbon consumption profile under the effect of MeOH and 
further investigation is needed. Nevertheless, this result indicates that the presence of 
  
 
MeOH positively influences lovastatin production, which is in contrast to our 
observation in the presence of CG. Therefore, it is unlikely that the presence of MeOH 
in CG contributed to reduced lovastatin production unless there is a different effect 
when the contaminants are present together in the media. 
4.2.2 Sodium chloride induced the production of lovastatin, (+)-geodin and 
sulochrin 
The effect of sodium chloride (NaCl) on the production of three metabolites of interest 
in A. terreus is shown in Figure 4.5. This salt constitutes about 0.2% of the total CG 
(w/v), although it is estimated that the total content of combined salts is much higher 
(part of MONG value, refer to Materials and Methods). It is evident that the presence of 
NaCl at low concentration (1 g/L) significantly enhanced lovastatin production (31% 
increase). This positive effect is, however, was reduced in a dose-dependent manner as 
the concentration of NaCl increased in the media. Production of lovastatin in 2 g/L of 
NaCl produced no significant difference with negative control while the highest 
concentration of NaCl (4 g/L) significantly reduced the production of lovastatin at day 6 
(31% decrease). The positive effect of NaCl was more obvious in (+)-geodin and 
sulochrin production, which was significantly induced at both 1 and 2 g/L of NaCl.  
It is likely that NaCl influence metabolites biosynthesis by regulating the osmotic 
pressure [71] of the cells or metal ions supplementation [55]. However, it is unlikely 
that sodium ion is responsible for the changes in the metabolite production, at least 
directly, since it is known that this cation is relatively inert [71]. Furthermore, no 
significant growth and substrate uptake inhibition took place (Table 3), which are 
among of the mechanism of sodium ion inhibition [104]. Therefore, the change of 
osmotic pressure is most likely the reason for the change, as also reported in A. niger 
  
 
[71]. The reduction of water inside the fungal pellet may also induce physiological 
changes, such as enhanced membrane permeability and enzyme synthesis [105,106]. 
However, the excessive osmotic pressure may cause adverse effects, such as osmotic 
plasmolysis  [107,108]. This effect was observed when 4 g/L of NaCl was added, as the 
fungal pellet swelled (larger diameter, with lower density) with some cell lysis observed 
(Table 4.3). The lysis was also probably the reason for the lower glycerol consumption 
(Table 4.3). This observation also supports the hypothesis that the production of (+)-
geodin and sulochrin being a stress-response mechanism as observed in CG experiment, 
as higher increase was more prominent in both metabolites (at 1 and 2 g/L, refer to 
Figure 4.5). This result shows that the presence of 2% NaCl in CG is not the factor that 
reduces metabolite synthesis by A. terreus,. It is possible that other uncharacterised salts 
inside the CG are responsible for the inhibition of metabolite production by A. terreus. 
  
  
 
 
Figure 4.5: Effect of NaCl addition on the metabolite production of A. terreus. A) 
Lovastatin was induced significantly at 1 g/L of NaCl. In B) and C), (+)-geodin and 
sulochrin were both induced significantly at 1 and 2 g/L NaCl.  Significance is when 
p<0.05. 
 
 
 
  
 
 0 g/L 1 g/L 2 g/L 4 g/L 
Biomass (g/L) 10.5 ± 0.3 10.6 ± 0.6  10.0 ± 0.5 11.2 ± 0.6 
Consumption rate 
(GLY/l/h) 
0.50 0.49 0.48 0.41 
Diameter of pellet 
(mm) 
3.0 ± 0.06 3.0 ± 0.09 3.0 ± 0.1 3.4 ± 0.06 
Table 4.3: The effect of NaCl on biomass concentration and glycerol consumption 
rate in shake flask experiment at 6 days. The glycerol consumption rate is reported at 
2 days due to the near complete conversion of glycerol at day 4. 95% confidence is used 
as the standard error. 
  
  
 
4.2.3 Effect of fatty acids on metabolite production by A. terreus 
The amount of fatty acids in CG can vary with the source of feedstock used in biodiesel 
production and is detectable by the presence of a black layer on top of the CG solution. 
For these experiments, oleic acid (OA) and palmitic acid (PA) were selected to 
represent single (saturated) and double bonded (unsaturated) fatty acids, while the 
collected soap from CG will represent the total amount of fatty acids salt. 
The biomass and carbon consumption profile for all three treatments are shown in Table 
4.4. For all treatments, the biomass growth increased as concentration of fatty acids 
increased, although the increase was more pronounced when OA is present. In contrast, 
decreased glycerol consumption was observed in all treatments when compared to the 
control experiment. It is likely that these fatty acids are consumed as an alternative 
carbon source [109,110], as these fatty acids administration increased the biomass 
growth,  and reduced the carbon consumption rate.  
The amount of lovastatin produced following treatment with selected fatty acids and 
soap is presented in Figure 4.6. Interestingly, OA addition induced lovastatin production 
only at the highest concentration used (3 g/L), while the addition of PA significantly 
reduced lovastatin production in a concentration higher than 0.3 g/L (>56%). On the 
other hand, the addition of soap significantly suppressed the production of lovastatin at 
all concentration (the lowest being 74%). However, the most noticeable effect was 
observed in (+)-geodin production, where all OA additions significantly increased (+)-
geodin’s production with 3 g/L OA increased (+)-geodin by nearly 6-fold. The increase 
can also be observed in sulochrin, although the increase was not as substantial as (+)-
geodin (~2-fold). However, the presence of PA gave the opposite effect, such that it 
repressed (+)-geodin and sulochrin production at all concentrations. The addition of 
  
 
soap (0.3 and 1.5 g/L) produced comparable (+)-geodin and sulochrin compared to the 
PG control, although the high amount of soap (3 g/L) reduced both (+)-geodin and 
sulochrin by almost 2-fold.  
Treatments 
Concentrations 
(g/L) 
Biomass 
(g/L) 
Consumption 
rate (GLY/l/h) 
Soap 
0 10.5 ± 0.3 0.50 
0.3 10.4 ± 0.2 0.49 
1.5 10.5 ± 0.4 0.44 
3 12.2 ± 0.5 0.39 
OA 
0 9.5 ± 1.2 0.43 
0.3 9.7 ± 1.1 0.40 
1.5 10.1 ± 1.4 0.35 
3 13.0 ± 1.4 0.32 
PA 
0 9.5 ± 1.2 0.43 
0.3 10.9 ± 1.8 0.41 
1.5 12.1 ± 2.4 0.37 
3 14.8 ± 1.2 0.36 
Table 4.4: The biomass and carbon consumption profile of A. terreus in the 
presence of different types of fatty acids. The production of biomass was either 
unchanged or increased in the presence of all treatments, while the consumption rate 
was reduced in all treatments. 
  
  
 
  
 
 
Figure 4.6: Effect of fatty acids addition on lovastatin production of A. terreus.  The 
lowest concentration of OA did not give any effect on lovastatin production, while 3 g/L 
induced lovastatin production significantly. The addition of PA greater than 1.5 mg/L 
caused significant inhibition of lovastatin production. Soap caused greater inhibition of 
lovastatin than any other fatty acids. A value of p<0.05 is considered significant. 
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Figure 4.7: Effect of fatty acids addition on (+)-geodin and sulochrin production of 
A. terreus. The production of (+)-geodin at 3 g/L of OA was significantly higher than 
any other metabolites, peaking at 265 mg/L on day 6. The production of (+)-geodin and 
sulochrin under the presence of PA were significantly suppressed. Only mild inhibition 
of (+)-geodin and sulochrin were observed in soap-treated media.Only 3 g/L of soap 
produced significantly lower metabolites compared to the control experiment. 
  
 
The benefit of double bonded fatty acids on fungi has been previously reported to 
improve cell signalling, membrane cell structure and the growth of the fungus [86,111–
114]. Saturated fatty acids, on the other hand, were shown to inhibit Aspergillus spp. 
metabolite production, possibly by penetrating the lipid membrane of the fungi and 
caused metabolic uncoupling [115]. Soap has been demonstrated to reduce the 
metabolite production via a few different routes. The inhibition may occur by the 
absorption of certain fatty acids (C18) by the microorganism [116] or due to the 
complex interaction of soap with the membrane of the organism [117]. This 
experimental result suggests that although unsaturated fatty acids, such as OA may be 
present in the soap, its stimulatory effect on lovastatin production might be masked by 
saturated or other type of fatty acids inside CG. As (+)-geodin and sulochrin production 
was not severely affected by the presence of soap, the benefit of OA in CG is probably 
one of the major factors that stimulate its production as observed in CG experimental 
results. Besides, MONG, which primarily comprise of fatty acids, constitutes a large 
portion (~20%) of CG component use in this study. Hence, the overall trend metabolite 
production by A. terreus, when CG was used, is most likely influenced by the presence 
of fatty acids or soap. 
We observed a different trend of metabolite production in a bioreactor, which would be 
discussed in the following section.  
  
  
 
4.3 Metabolite production in bioreactor 
The concentration of CG or PG used in bioreactor experiments was 30 g/L, which was 
chosen based on data obtained from shake flask experiments. Figures 4.8a show 
glycerol consumption and biomass production for up to 7 days. Consistent with our 
observations in shake flask experiments, CG showed reduced glycerol consumption 
compared to PG. Glycerol was completely exhausted by day 3 in PG, but this was 
delayed in CG until it was exhausted at day 4. The quality of substrate also has little 
effect on the growth of A. terreus. The final biomass obtained from PG (6.3 g/L) and 
CG (6.0 g/L) was not significantly different (p<0.05), indicating that  A. terreus was 
able to produce comparable biomass to PG, when CG was used as the substrate. The 
only difference observed was the structural integrity of pellet. Instead of spherical and 
fluffy pellet, noticeable breakage and disintegration of the pellet was observed in both 
PG and CG experiments, due to the effect of the shear force of the bioreactor. Overall, 
these observations follow and confirm the experimental data obtained from shake flask 
experiments in the previous section.  
The metabolite production of A. terreus in bioreactor showed a higher production of 
lovastatin, as opposed to shake flask experiment, as shown in Figure 4.8B. Lovastatin in 
PG (52.25 mg/L, day 6) was shown to be significantly higher than shake flask 
experiment (shake flask = 19.48 mg/L, day 6). No significant changes in lovastatin 
production was observed when CG was used (14.48 mg/L versus 10.07 mg/L, day 6). 
This oservation suggests that lovastatin production from PG can be greatly enhanced 
with better oxygen and aeration control that is possible in a large-scale application such 
as bioreactors. The main differences in bioreactor experiments compared to shake flask 
experiments, particularly when PG was used as the substrate, were the production of 
  
 
(+)-geodin and sulochrin as shown in Figure 4.8b. Up to 67.89 mg/L and 35.55 mg/L of 
(+)-geodin and sulochrin were obtained, respectively, using the bioreactor when using 
PG. This rise was equivalent to 838% and 308% rise compared to shake flask 
experiment, respectively. This particular result is interesting for a few reasons. First, 
only low production of (+)-geodin and sulochrin were detected in shake flask 
experiments, whereas they were express at a greater concentration in a bioreactor. 
Second, the (+)-geodin production was very high, but the production of sulochrin did 
not increase as much (Previous chapters have shown that these two metabolites usually 
share the same pattern of production). Third, and perhaps the most important, is the 
significant increase in (+)-geodin at day 4, which corresponded with the disintegration 
of pellet due to the shear stress resulting from oxygen bubbling and the contact with 
Rushton-type impeller. In addition, as the culture aged, the media turned dark brown, 
indicating an increase in metabolites production (see Figure 4.9). This colour change 
was also observed by Bizukojc M. et al. in their experiment [60], which was attributed it 
to an increase in lovastatin production. However, such change with an increase in 
lovastatin production was not observed in our hands in shake flask experiment. 
Therefore, we are inclined to believe that the colour change may be caused either by an 
increase in  (+)-geodin or sulochrin production. 
Conversely, the production of (+)-geodin and sulochrin in CG did not differ as much as 
its shake flask counterparts. Nevertheless, the production of (+)-geodin was observed to 
increase after day 4 when similar breakage of the pellet was observed. Such low 
metabolite production, when CG (see previous paragraph for comparison) was used, 
may occur due to the higher assimilation of impurities in the culture into the cells as a 
result of constant stirring and dissolved oxygen content. The increase of lovastatin, (+)-
geodin and sulochrin in PG was as a result of better cultivation conditions, such as 
  
 
improved oxygen control  and superior aeration  in bioreactor [36]. Given than the two 
compounds require oxygen in the post-modification steps, higher oxygen levels in 
bioreactor may favour and enhance their production. However, the production of (+)-
geodin is possibly affected by another factor – the integrity of fungal pellet. This fact is 
proven by the increase of this metabolite as the integrity of fungal pellet was 
compromised by mechanical force. Again, this result indicates a possible role for these 
metabolites, especially (+)-geodin and sulochrin,  in responding to stress. This factor is 
explored further in the next chapter (Chapter 5).  
 
  
  
 
 
  
  
Figure 4.8: The effect of PG and CG glycerol on metabolite production by A. 
terreus cultivated in bioreactor over 7 days. The initial glycerol concentration was 30 
g/L. From top: A) Glycerol consumption and biomass production and B) Metabolites 
production. In (A), the quality of glycerol did affect the glycerol consumption but not 
biomass production. In (B), the overall metabolites production quantity was improved in 
PG, but not in CG. (+)-geodin’s production showed an interesting trend in PG, as a 
significant increase was observed starting at day 4.  
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Figure 4.9: The gradual change of colour observed during the cultivation of A. 
terreus. The images were taken in every two days, up to day 8. 
 
4.4 Pre-treatments strategy to improve Crude Glycerol utilisation by A. 
terreus 
Microbial bioconversion is often more efficient when using a defined carbon source 
with low content of inhibitory compounds. Apart from what we have discussed in the 
earlier sections, we investigated the pre-treatments of  CG used in this investigation 
using non-polar solvents, activated carbon and water softener pillow. The treatments 
produced a noticeable change in the colour and physical appearance of CG, as shown in 
Figure 4.10. The chemical changes following pre-treatment of CG are discussed in the 
next few subchapters. 
  
 
 
Figure 4.10: The pre-treatments produced different colours on the CG. (A) 
Untreated crude glycerol in deep yellow. (B) Lighter yellow produced from petroleum 
ether treatment. (C) Lighter yellow from toluene treatment. (D) Lighter yellow from 
diethyl ether treatment. (E) Almost clear solution from activated carbon treatment. (F) 
Lighter yellow from water softener pillow treatment. 
  
  
 
4.4.1 Comparison between the growth, substrate consumption and metabolite 
production using crude, pure and non-polar solvent pre-treated glycerol  
Solvent washing is a simple method of separating a compound based on the different 
solubilities of two immiscible liquids. This method is efficient in reducing certain fatty 
acids in the solution [118]. By extracting of the impurities from the CG to the organic 
solvent of interest, we can improve the overall quality of the CG. In our investigation, 
we opted to use petroleum ether (PE), diethyl ether (DE) and toluene (Tol) as our 
solvent of interest. Rehman et. al (2008) was among the first team to use this technique 
on CG, achieving a good microbial bioconversion [119].  
As depicted in earlier investigations, the growth of A. terreus had a little change (~3%) 
when the negative control (CG) was used compared to the positive control (PG). The 
use of pre-treated solvents produced good biomass, which was comparable or exceeded 
that observed with PG (Table 4.5). DE showed the highest biomass production (11.28 
g/L), followed by PE (10.60 g/L), PG (10.07 g/L) g/L), Tol (9.80 g/L), and CG (9.75 
g/L). The high production of biomass was thought to result from the residual fatty acids 
that are still present in pre-treated CG, given that the solvent washing cannot entirely 
remove them from the solution [118]. The increase in biomass in the presence of fatty 
acids has been discussed previously (Section 4.2.3). The use of pre-treated CG also 
increased the biomass , although to a lesser extent, indicating that there were probably 
less fatty acids remaining in the pre-treated CG, compared to what has been investigated 
in Section 4.2.3 (non-purified CG). Nevertheless, we could not deduce the accurate 
reasons due to the lack of necessary equipment to analyse the exact composition of CG 
before and after the treatments. 
  
 
Treatments DE PE Tol CG control PG control 
Biomass (g/L) 11.28±0.30 10.60±0.27 9.80±0.22 9.75±0.12 10.07±0.10 
Table 4.5: The biomass production of A. terreus under different pre-treatments of 
non-polar solvents. The standard errors represent 95% confidence. 
Evidently, the pre-treatments of CG with these solvents improved the glycerol 
consumption significantly (up to 50% improvement) when compared to non-treated CG 
media (Figure 4.11). This may be possible as a result of the solvent effects in reducing 
most of the free and methyl ester fatty acids in the CG. However, as discussed earlier in 
section 4.2.3, we think that the consumption of glycerol in the presence of fatty acids 
may be lower than PG media due to substrate competition (as fatty acids may probably 
be the preferable carbon source) or due to the inhibitory effect of fatty acids on carbon 
uptake.  
The production of lovastatin, (+)-geodin and sulochrin using pre-treated CG is depicted 
in Figure 4.11. PE, in particular, showed an impressive 92.8% increase in lovastatin 
production at day 6 compared to the PG control experiment. The final titre of lovastatin 
at day 6 for both DE and Tol, unfortunately, was insignificant to the positive control. 
Interestingly, a different response was observed in (+)-geodin and sulochrin production. 
Instead of PE (5.58 g/L), DE (8.95 mg/L) induced (+)-geodin the strongest, while 
sulohrin is more responsive to Tol pre-treatment (24.78 g/L). This result is still 
considered excellent nonetheless, because substantial improvement in metabolite 
production, as well as glycerol consumption, was achieved when compared to the CG 
(negative) control (Figure 4.11). 
  
 
The improvement of lovastatin production can be attributed to the ability of the solvent 
to remove some of the contaminants. Previous investigation showed that certain 
solvents can remove several key fatty acids in CG, such as linoleic acid methyl ester, 
palmitic acids and oleic acids [118]. Although some the beneficial fatty acids are also 
being removed (for example, oleic acid – refer to subsection 4.2.3), the removal of 
inhibiting saturated fatty acids such palmitic acids was shown to have a larger effect on 
the lovastatin production by this fungus. It is possible that the induction of lovastatin 
production in PE is caused by the incomplete removal of unsaturated fatty acids in the 
treatment. The incomplete removal may also be the reason why we observed a mixed 
response of (+)-geodin and sulochrin as well (Figure 4.11). The incomplete removal of 
multiple types of fatty acids in CG provoked different reaction in (+)-geodin and 
sulochrin, such that higher (+)-geodin was observed in DE treatment (8.95 mg/L), while 
higher sulochrin was detected in Tol (24.78 g/L). It might be that each of these 
metabolites is induced more strongly by different impurities, which resulted in a unique 
response in different pre-treatments (further discussed in Chapter 6: Future Direction).  
To investigate further, a subsequent investigation involving the complete removal of 
fatty acids using soap precipitation technique on CG was conducted (describe in 
Chapter 2: Materials and Methods). This technique yielded even higher lovastatin 
production, up to 2-folds (63.25 mg/L). Interestingly, the production of (+)-geodin and 
sulochrin was suppressed (very little to non-existent), similar to that observed in 
MeOH’s investigation (Section 4.2.1). It is possible that the suppression of (+)-geodin 
and sulochrin was partly contributed by contributed by other impurities, such as MeOH, 
which was still present in the treated CG. 
  
 
It is important to note that the authors of the study stressed the differential effect of pre-
treatments when the different source of CG was used [118]. Therefore, it is possible that 
while the pre-treatments might be effective in one type of CG, it might not be so useful 
in other type of CG. Hence, a standard method should always be performed to achieve 
the optimal result in purifying a particular CG. 
  
  
 
 
  
Figure 4.11: The glycerol consumption and metabolite production of A. terreus 
when under different solvent pre-treatments. (A) Lovastatin production is the highest 
at day 6 in PE treatment and in the absence of soap. (B) (+)-geodin production is the 
highest in DE treatments at day 6. (C) Sulochrin production is the highest in the Tol 
treatment at day 6. (D) The consumption of CG is the slowest compared to all 
treatments. The negative control is represented by an untreated CG while positive 
control is PG. 
 
 
  
 
4.4.2 The efficiency of non-liquid pre-treatment technique of crude glycerol on 
substrate consumption, growth and lovastatin production 
In our previous investigation, we used solvent extraction to improve the quality of CG. 
In this section, we are trying to use solid substances to improve CG and A. terreus 
fermentation. Our substances of choice are activated carbon (AC) and water softener 
pillow (WS). AC is a form of carbon material that has been treated with oxygen by 
thermal decomposition to create millions of pores that increase the surface area 
available for absorption. While solvent washing involved the reduction of impurities by 
transferring the impurities from one liquid to another, AC concept is about the trapping 
and filtering of the impurities inside the CG. On the other hand, the aim of using WS is 
to reduce the “hardness” of the solution, which is the indication of the presence of 
minerals, such as calcium and magnesium. While there is no evidence that associate the 
effect of hard water on the growth or production of metabolites by fungus, recent 
evidence showed that divalent metal cations can influence lovastatin biosynthesis [55]. 
Moreover, the presence of certain metal ions together, in certain concentrations, may be 
potentially inhibitory to lovastatin production. 
Our initial analysis addressed whether the treatments would alter the composition of 
glycerol inside CG. However, the post-glycerol analysis showed a little change of 
glycerol, which indicates that the treatments did not interfere with the glycerol content 
(less than ~2% differences). The CG treated using solvent washing, and WS did not 
really change in their physical look, but AC treatment produced a clear and odourless 
solution which is comparable to that of PG (refer to Figure 4.10). 
Our subsequent analysis showed an improvement in term of substrate consumption 
when compared to CG when AC and WS (42% and 22% improvement, respectively at 
  
 
day 2) was used (Figure 4.12). However, no improvement in biomass growth was 
detected under both treatments. The higher rate of improvement when AC was used 
indicated that this technique is probably more beneficial to the fungal growth, most 
likely by improving the flux of substrate into the fungal cell. This observation also 
indicates that the reduction of cations (by reducing the water hardness using WS) would 
still improve the consumption, but is probably limited by the presence of non-dissolved 
solids inside the CG.  
Figure 4.13 shows the production of lovastatin, (+)-geodin and sulochrin using either 
non-treated CG or CG pre-treated with AC, WS, PG and CG for 6-days cultivation. The 
production of lovastatin (21.80 mg/L), (+)-geodin (7.43 mg/L) and sulochrin (11.74 
mg/L) following AC treatment was very similar to PG (20.65 mg/L, 8.60 mg/L and 8.18 
mg/L, respectively). In contrast, WS’ metabolite productions (CLOV = 11.25 mg/L, CGEO 
= 12.34 mg/L, CSUL = 12.85 mg/L) mirrored CG (CLOV = 7.10 mg/L, CGEO = 17.10 
mg/L, CSUL = 14.78 mg/L) . This suggests that the AC treatment produced almost 
“pure” substrate, comparable to PG, while WS treatment failed to improve the quality of 
the cultivation given that its production pattern resembles that of CG. These 
observations also support our earlier observation on the effect of these treatments on 
glycerol consumption, where AC treatment proves to be the best treatment between 
those two. As expected, WS treatment and CG control produced higher (+)-geodin and 
sulochrin due to the higher presence of impurities. This observation, again, supports that 
(+)-geodin and sulochrin are more responsive towards impurities, and may be indicative 
of their role in stress-related mechanism in A. terreus.   
 
  
 
 
Figure 4.12: The glycerol consumption and biomass growth by A. terreus under the 
treatment of AC and WS. A) Glycerol consumption. B) Biomass production. In A), 
the glycerol consumption in AC improved considerably, similar to positive control. In 
B), the biomass production was not affected by the pre-treatments.  
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Figure 4.13: The lovastatin, (+)-geodin and sulochrin by A. terreus under the 
treatment of AC and WS. A) Lovastatin production. B) (+)-geodin production C) 
Sulochrin production. Lovastatin, (+)-geodin and sulochrin production in AC mirrored 
positive control (PG), while these metabolite production in WS mirrored negative 
control (CG). 
 
  
  
 
4.5 Conclusion 
We have shown that A. terreus strain can grow and produce metabolites using CG as its 
carbon source, albeit with a reduced lovastatin production. Based on the experimental 
data using foreign substances found in CG, we concluded that certain type salts (such as 
sodium phosphate) and saturated fatty acids are the main inhibitor for lovastatin 
production. While octaketide compounds have been suggested to have a relationship 
with lovastatin production, we did not observe such relationship, at least with (+) -
geodin and sulochrin. Although CG may not be a better carbon source than PG for 
lovastatin production, it is indeed a promising economic and environmental alternative 
to make full use of easily accessible bio-wastes. 
 
  
  
 
Chapter 5 - Enhancement of metabolite production in A. terreus by 
chemical, biological and natural factors 
5.0 Introduction 
In the previous chapter, we found that the production of metabolites can be stimulated 
by different factors i.e. osmotic pressure, fatty acids and possibly by shear force (in the 
bioreactor). As CG is a dirty substrate; it is likely that there will be substances that may 
provoke the fungus’ defense system inside CG. This chapter is the continuation of the 
previous chapter where the possible mechanism of CG and pattern of metabolite 
production will be investigated by using a known compounds or techniques using the 
purified CG from AC. 
Since the early 1970s,‘elicitors’ have been shown to trigger the synthesis of secondary 
metabolites by stimulating the organism’s defense system. This response is part of the 
microorganisms’ normal reaction to so-called ‘threat’ molecules, usually associated 
with survival, persistence and competitiveness. An initial elicitation study has been 
conducted on plant culture system [120]. Since then, the term ‘elicitor’ has been also 
used in other organisms, including fungi and bacteria [121]. An elicitor may be present 
in the form of physical or chemical, biotic or abiotic, and complex or defined, 
depending on its source and molecular structure (Table 5.1). In fungal cell culture, 
certain types of complex carbohydrates (oligosaccharides and polysaccharides) are the 
major sources of biotic elicitors; this includes sodium alginate [122]. 
Alginates can be classified as linear polysaccharides produced by some bacterial species 
and brown algae. The main building blocks of alginates are two different hexuronic 
acids: β-d-mannuronic acid (ManA) and α-l-guluronic acid (GulA), linked by α1–4 
  
 
bonds [123]. Studies have demonstrated that alginates can trigger the immune system in 
different organisms, making them an excellent biotic elicitor. In a fungal cell study, 
alginate treatment improved the activity of the glucose oxidase—a cell marker for 
defense mechanism—by almost 50% [122]. Furthermore, treatment with alginate and its 
derivatives induced the major penicillin biosynthetic pathway (pcbAB, pcbC and 
penDE) in penicillin-producing fungi without changes in fungal biomass [121]. Apart 
from penicillin, these carbohydrates also stimulate the production of pigments such as 
chrysogenin in the same family of fungi [124].  
Cholesterol may also act as an elicitor for lovastatin production based on its negative 
feedback mechanism. As discussed earlier in the introduction chapter, lovastatin is a 
cholesterol inhibitor of HMG-CoA reductase. The production of lovastatin is a result of 
the defense mechanism of A. terreus in response to other organisms that require sterols 
as their main constituents [13]. This led us to propose that A. terreus may have a 
sensory mechanism to detect any sterol-related compound near its vicinity. Hence, any 
addition of sterile-related compound could trigger its defense mechanism and 
consequently induces the production of lovastatin.   
The setup of the experimental procedures for the chemical elicitation experiment in this 
chapter is summarised in Table 5.2: 
  
 
Elicitors Organism (s) 
Physical Injury P 
Chemical 
Abiotic Metal ions (lanthanum, europium, calcium, silver, cadmium), oxalate PC 
Biotic 
Complex Yeast cell wall, mycelia cell wall, fungal spores PC, F 
Defined 
Carbohydrates 
Polysaccharides 
Alginate PC, F, B 
LBG F 
Pectin PC, F 
Chitosan PC 
Guar Gum PC 
Oligosaccharides 
Mannuronate F 
Guluronate F 
Mannan F 
Galacturonides PC 
Proteins 
Peptides Glutathione PC 
Proteins Cellulase, Elicitins, Oligandrins PC 
Lipids  Lipopolysaccharides PC 
Glycoproteins  Not characterised PC 
Volatiles  C6 – C10 PC 
Table 5.1: Compilation of possible elicitors used in different organisms. Abbreviations 
used: P – Plants, PC – Plant cell culture, F – fungi, B – bacterial cell culture. Adapted from 
[121].  
  
 
Number Treatments 
Concentration Viscosity 
(mPA.s) mg/L mL/L 
1 
Sodium Alginate (SA) 
50 NA 300.21 
2 100 NA 713.75 
3 200 NA 1100.32 
4 
Gelatine (positive control) 
75 NA 301.32 
5 150 NA 708.17 
6 400 NA 1113.01 
7 
Alginate without calcium 
ion (positive control) 
50 NA 15.02 
8 100 NA 70.43 
9 200 NA 126.96 
10 
Cholesterol 
100 NA NA 
11 500 NA NA 
12 1000 NA NA 
13 Negative control 0 0 4.77 
Table 5.2: Experimental plans to investigate elicitation in A. terreus. Each experiment is 
performed at least in triplicates, using the same spore source to avoid variation. All 
elicitors were added after 24 hours of fungal culture initiation. In this chapter, the experiment 
was performed for 9 days with sampling every 3 days. 
  
  
 
In Chapter 4, the production of (+)-geodin was significantly stimulated in a bioreactor 
system. Fungal cultivation in bioreactor caused the fungal pellet to break, due to the high 
shear pressure and contact between the Rushton-type impeller with fungal pellets. Therefore, 
we hypothesised that the production of these metabolites, especially (+)-geodin, is related to 
pellet integrity. However, Sainz and colleagues reported that [45] sonication suppressed both 
morphology (by reducing the size) and lovastatin production by A. terreus, although no 
measurement of (+)-geodin and sulochrin was done. In this chapter, the effect of shear 
pressure (introduced via friction and sonication) or ‘physical elicitation’ on A. terreus will be 
investigated.  
Malonic acid is mainly known as a competitive inhibitor of succinate dehydrogenase in the 
citric acid cycle [125]. A. terreus is a complex microorganism that utilises this cycle to 
produce energy. The introduction of malonic acid may be fatal for this organism due to its 
inhibitory effects on key metabolism. However, fungi are robust species, and partial 
inhibition of energy metabolism may increase the metabolite production instead, due to the 
increased availability of the precursors for metabolite production. In higher organisms, 
especially plant, malonic acid has been shown to be beneficial due to its conversion into 
malonyl-CoA, which is an important precursor in all living organisms [126]. Thus, malonic 
acid might probably be utilised to some extent in fungi species too, as part of their normal 
metabolism although their specific role is yet unknown. 
The setup of the experimental procedures for other stimulatory factors in this chapter is 
summarised in Table 5.3. 
  
  
 
 
Number Treatments 
Amount/type 
mg/L Type 
1 
Malonic acid 
100 Chemical 
2 300 Chemical 
3 500 Chemical 
4 Friction NA Physical 
5 Sonication NA Physical 
6 Negative control NA NA 
Table 5.3: Experimental design involving other stimulatory factors for metabolite 
production by A. terreus. All the experiments were performed with a minimal of triplicates. 
Similarly, all the experiments were performed for 9 days with sampling taken at every 3 days. 
  
  
 
5.1 Elicitors 
5.1.1 Sodium alginate improved lovastatin early in cultivation and induced unique 
pattern of octaketide metabolite production 
Sodium alginate (SA) can form viscous gum upon contact with water that contains calcium 
ion, which is part of our media composition. Given that viscosity may influence the 
production of metabolites by Aspergillus species [127], a positive control containing gelatine 
was used to mimic the viscosity effect of SA. To study the effect of SA without the presence 
of calcium (thus having low viscosity), a second positive control was set up (SA2).  
The biomass production of this culture in SA-treated media and gelatine was higher than that 
of SA2 and the negative control (Table 5.4). In SA2, only a slight increase in biomass was 
observed at all three concentrations. Treatment with SA of 200 mg/L and gelatine of 400 
mg/L produced the highest biomass increase (44% and 42% respectively). This was then 
followed by treatments with SA (100 mg/L) and gelatine (150 mg/L), resulting in an increase 
of 41% and 34.4% respectively. These observations show that viscosity plays a key role in 
biomass production, but elicitation only play a minor role. Higher biomass production in 
higher viscosity media is likely to have been contributed by the viscosity-protective effect, as 
this effect allowed a better distribution and protected the fungal cell from the sheer force of 
the mixing rate [127]. High viscosity is also favourable for growth in a number of different 
fungi [42,128,129]. 
  
  
 
 
Treatment Concentration 
(mg/L) 
Biomass 
(g/L) 
Diameter 
(cm) 
Density  
(g/m
3
) 
SA 
50 11.2 3.2 ±0.03 0.65 
100 12.7 3.3±0.05 0.68 
200 13.0 3.3±0.06 0.69 
Gelatine 
75 10.4 3.1±0.06 0.67 
150 12.1 3.2±0.05 0.71 
400 12.8 3.2±0.05 0.75 
SA without calcium 
ion (SA2) 
50 9.0 3.1±0.04 0.58 
100 9.5 3.1±0.04 0.61 
200 10.3 3.1±0.05 0.66 
Negative control NA 9.0 2.9±0.06 0.71 
Table 5.4: Biomass, diameter and density of A. terreus under different media treatments 
in the elicitation experiment. Increasing the viscosity (measured by increasing 
concentration) contributed to the increase of biomass. 
  
 
The pattern of lovastatin production is shown in Figure 5.1. Lovastatin production was 
significantly higher in all treatments with SA compared to the negative control. Treatment 
with 200 mg/L of SA produced the highest production (329% compared to the negative 
control), followed by treatment with 100 mg/L of SA, producing a production of 203% at day 
9. However, the most notable feature of SA treatment was the timing of lovastatin 
production. A significant increase in lovastatin production could be observed as early as day 
3 (729% increase at 200 mg/L SA), while none yet was produced in any of the controls, 
which indicates the immediate effect of SA on metabolite production. The rapid onset may be 
attributed to SA’s ability to induce enzyme activity within a short period. For instance, in 
Penicillium variabile P16, the increase of enzyme activity was detected as soon as 24 hours 
after the addition of SA and SA-type elicitors [122].  
In contrast to SA-treatment, only slight non-significant improvement in lovastatin production 
was observed in gelatine-treated media (41.5% at 75 mg/L gelatine, day 2). In fact, high 
gelatine concentration (300 mg/L) produced lower lovastatin titre (CLOV = 6.23 mg/L) when 
compared to the negative control (10.86 mg/L). Most likely, the high viscosity media is less 
optimal for metabolite production due to the decreasing mass transfer, heat transfer and 
oxygen transfer [130]. However, this finding is in contrast with the observation in A. niger, 
where significantly higher metabolite was produced when higher viscosity media was used in 
shake flask cultivation [127]. This finding indicates that different fungus may have different 
requirements for metabolite production. In the aforementioned study in A. niger, it was 
shown that the morphology and metabolite production of this fungal strain were sensitive to 
shock and agitation speed introduced in their experimental model [127]. The introduction of 
higher viscosity media protects the morphology of A. niger, thus resulted in higher metabolite 
production. A. terreus however, was more resistant to much higher shear force caused by the 
agitation speed [34]. However, the significant increase of lovastatin production only in the 
  
 
presence of SA highlights that there is a synergistic effect between viscosity and elicitor, as 
the SA2 control (without viscosity) produced significantly lower lovastatin than SA-treated 
media.  
Under normal circumstances, the increase of (+)-geodin production was usually followed by 
a similar rise in sulochrin production (Figure 5.1). This pattern was expected as both 
metabolites are octaketide compounds derived from the same pathway. However, a different 
pattern of production for each metabolite was observed in SA and gelatine-treated media. The 
production of (+)-geodin was suppressed in SA and gelatine, but not in SA2 and the negative 
control. On the other hand, sulochrin production was increased in SA and SA2. These 
observations suggest that (+)-geodin production is influenced by the viscosity of the media, 
while sulochrin production is dependent on the presence of elicitor. A significant increase in 
(+)-geodin was also observed in the bioreactor (Chapter 4: Crude glycerol) too, when the 
shear pressure was high. As higher viscosity translates into low shear pressure, this is likely 
the reason why the (+)-geodin’s production was low.  
In contrast to lovastatin production, which plateau after day 6, (+)-geodin and sulochrin 
production showed an active trend up to day 9. Production of sulochrin increased 
significantly on day 9 when compared to day 6 (previous time point) in all treatments tested. 
This observation suggests a role of sulochrin as a late metabolite. On the other hand, 
production of (+)-geodin peaked at day 6, but decreased at day 9. Reduction of (+)-geodin 
after day 6 might have been caused by the depletion of carbon source towards the end of 
fungal cultivation [74]. However, the reduction may also occur as a result of degradation, or 
being consumed by the fungus for its normal function [60].  
  
 
 
Figure 5.1: Lovastatin, (+)-geodin and sulochrin production under different media 
treatments in the elicitation experiment. The graphs showed A) Lovastatin production, B) 
(+)-geodin production and C) sulochrin production. Experiments were conducted for 9 days 
using at least triplicates. Error bars represent 95% confidence interval. 
  
  
 
The next part of the study evaluated morphological features of A. terreus. All of the pellets 
exhibited full-grown hair on their surface, which is an early indicator of high lovastatin 
production in the media [34]. A study by Porcel R. et al. showed that one of the factors that 
affect the production of hair is the shear force inside the media [33]. By measuring the length 
of hair (which later is defined as “filament ratio”), they concluded that high shear force might 
cause retraction of hair into the pellet, which would eventually lead to lower lovastatin 
production [33]. It is unclear how the length of hair affects lovastatin production.  The 
“presence” of hair, rather than the length, is probably more important as observed by Lopez 
C. et al. [34]. In addition, it has been found that the pellet with hair, which exhibited soft, 
loose and less dense structure, is also optimal for lovastatin production [33].  
  
  
 
 
  
Figure 5.2: The morphology of pellets commonly observed in A. terreus cultivation. The 
presence of hair is usually associated with soft, loose, and less dense pellet (in B) compared 
to the hairless pellet (in A), with the tendency to clump. 
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The carbon (glycerol) consumption profile of A. terreus also showed an interesting trend 
(Figure 5.3). The consumption of glycerol in SA, gelatine and SA2 were all higher than the 
negative control, but not significantly different from each other. The introduction of viscosity 
is most likely improved the nutrient transfer from the media into the fungus, which improved 
its consumption capacity [32,131].  As usual, the sharpest decline in glycerol concentration 
occurred in the first 2 days, due to a higher requirement of carbon sources for growth and 
metabolite production.  
 
 
Figure 5.3: Glycerol consumption by A. terreus under the addition of elicitors over the 
period of 9 days. All treatments, as well as the positive control, showed an improvement in 
substrate consumption compared to the negative control. 
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5.1.1.1 Confirmation of Sodium Alginate as elicitors using bacteria 
Another investigation was set up to confirm the role of SA as an elicitor. In several batches of 
experiments, the pre-culture media (with fungal spore in it) was contaminated by unidentified 
bacteria (Figure 5.4), most likely from the bacillus species, identified from its rod-shape 
morphology under a light microscope. The contamination is easily spotted by its foul-
smelled, muddy solution with the presence of dwarfed pellets after 24 hours. It is 
hypothesized that this bacterial species would provoke the defense system of A. terreus 
similar to SA. 
Initial optimization experiment indicated that A. terreus cannot compete with this bacterium 
during the first 48 hours of cultivation. However, the addition of any bacteria stock after 48 
hours did not give any physical changes or further contamination on the fungal pellet. This 
observation indicates that the fungus has been most likely matured enough to ward off 
contaminations after certain stages of growth. 
The production of metabolites using bacteria as elicitor is depicted in Figure 5.5. The 
metabolite production response bore a very close resemblance to the production of 
metabolites when SA was used, particularly with lovastatin and sulochrin. This pattern 
confirms that both metabolites produced as a response to elicitation. The initial increase in 
lovastatin production that was observed in SA during the initial cultivation  was also evident 
when bacteria was used. (+)-geodin’s production, however, is more similar to control’s 
production which suggested that viscosity is more related with (+)-geodin’s production. 
  
  
 
 
Figure 5.4: The contamination and subsequent isolation of the contaminating bacterial 
strain. From top: (A) Differences between non-contaminated (left) and contaminated (right) 
culture of A. terreus. (B) Subsequent culture on PDA plates showed the growth of A. terreus 
(left) and bacteria (right).  
  
 
 
Figure 5.5: The metabolite production profile of A. terreus with the addition of bacterial 
stock after 48 hours. The lovastatin and sulochrin production follow a similar pattern with 
SA, while (+)-geodin production closely resembles control experiment. The graphs showed 
A) Lovastatin production, B) (+)-geodin production and C) sulochrin production. 
  
 
5.1.2 Cholesterol induces metabolite production by improving the overall growth rather 
than inciting defense mechanism of Aspergillus terreus 
The metabolite production of A. terreus under different concentrations of cholesterol is 
illustrated in Figure 5.6. The addition of cholesterol increased lovastatin production at all 
concentrations tested. However, the increase was insignificant at day 3 in a non-
concentration-dependent manner. Only at day 6, the difference became clear, as an increase 
of 63.6% and 77.40% in lovastatin production was observed in 1000 mg/L and 500 mg/L of 
cholesterol, respectively, while lowest addition of cholesterol (100 mg/L) of cholesterol did 
not produce any noticeable difference compared to the negative control. This suggests that 
unlike elicitors (e.g. sodium alginate), the effect of cholesterol is not immediate, and 
therefore may not act as an elicitor. This, however, can only be confirmed by measuring the 
gene expression and carbon flux of the fungus. (+)-geodin and sulochrin production also 
showed an opposite pattern compared to the elicitor experiment. This time, both of the 
metabolites are stimulated together in a concentration-dependent manner at the end of 
cultivation (day 6), which suggested that the increase of metabolites was fuelled by the 
increase of cholesterol in the media.  
Table 5.5 summarises the effect of cholesterol on substrate consumption and biomass of A. 
terreus. Only a slight improvement in substrate consumption was observed in cholesterol-
treated media. Biomass production has been found to increase with increasing concentration 
of cholesterol, in higher proportion compared to the elicitors experiment. Further analysis of 
cholesterol quantitation showed a reduction of cholesterol amount in the media by 9.3%, 
15.7%, and 12.5% (from 100 mg/L, 500 mg/L, and 1000 mg/L cholesterol respectively) on 
day 6 of cultivation. The uptake of cholesterol by A. terreus has never been documented 
before, although this has been demonstrated in other filamentous Aspergillus species [132]. 
  
 
Recent evidence also showed that sterol-related compound can be transported into the fungi 
under certain conditions [133]. Cholesterol treatment also produced clear media, with white 
and fluffy pellets that indicate the optimal morphology for metabolite production. The 
negative control, on the other hand, produced a brownish and slightly cloudy solution. Hence, 
the increase of metabolites may be due to the overall improvement of fungal growth, rather 
than being seen as a threat that would incite the fungus’ defense system.  
  
  
 
  
Figure 5.6: Lovastatin, (+)-geodin and sulochrin production in A. terreus under 
cholesterol treatment during 9-day cultivation. The lowest addition of cholesterol (100 
mg/L) did not affect the production of any metabolites. The graphs showed A) Lovastatin, B) 
(+)-geodin and C) sulochrin production. 
  
 
    Treatment  Consumption 
rate (day 2) 
Consumption 
rate (day 4) 
Biomass 
(g/L) 
Diameter 
(mm) 
Cholesterol 
100 mg/L 
5.08 2.82 11.4±0.1 3.2 
Cholesterol 
500 mg/L 
5.19 2.83 13.4±0.06 3.2 
Cholesterol 
1000 mg/L 
5.30 2.89 14.8±0.1 3.3 
 
Negative 
Control 
4.34 2.93 10.1±0.12 3.0 
Table 5.5: The consumption rate and growth of A. terreus under cholesterol treatment 
during 9-day cultivation.  Noticeable increase in biomass and diameter could be observed 
when cholesterol is present in the media. 
 
  
  
 
5.2 Other stimulating factors of Aspergillus terreus 
5.2.1 Malonic acid inhibits A. terreus growth and metabolite production only during 
early stage of growth 
The pellet’s weight and size were measured every 2 days to investigate the effect of malonic 
acid (MA) on the growth of A. terreus (Figure 5.7). On day 2, MA-treated media produced 
significantly lower biomass compared to the positive control, suggesting an inhibitory effect 
of MA on biomass production. Surprisingly, the growth recovered by day 4, and exceeded the 
control’s biomass by day 6. However, the size did not improve towards the end of the 
cultivation, which is significantly smaller than control experiment. This observation indicates 
that the fungus is still growing in the presence of MA, but only increase in density rather than 
size.  
Overall, these observations indicate that A. terreus may not be able to tolerate MA in the 
early stage of growth, but developed tolerance to MA in the later stages of growth. The 
addition of MA may provide additional precursor (malonyl-CoA) that is largely required for 
the growth of A. terreus [134]. The ionised form of MA, malonate, is a precursor to malonyl-
CoA that is needed in many metabolic processes of living organisms, including fatty acid 
biosynthesis. However, MA may be highly toxic due to its function as a competitive inhibitor 
of the electron transport chain, an important process of the energy-producing cycle in living 
organisms. This observation is further supported by a decrease in biomass (compared to 
control) during the early stage of cultivation (day 2) and the suppression of hair growth on the 
fungal pellet. It is currently unknown why the diameter of the fungus never recovered. 
  
 
 
Figure 5.7: Biomass growth and diameter of A. terreus over the period of 6 days. The 
biomass of MA-treated fungal was suppressed during early cultivation, but recovered towards 
the later stage. However, the diameter never recovered. Open symbols represent the biomass 
production while close symbols represent the diameter of A. terreus. 
 
Figure 5.8: Substrate (glycerol) consumption by A. terreus in shake flask. Glycerol was 
consumed the fastest by the control during early cultivation.  
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MA also hampered substrate consumption in a concentration-dependent manner (Figure 5.8). 
At day 2, the glycerol consumption in 100 mg/L, 300 mg/L and 500 mg/L of MA was 
reduced by 13.7%, 29.0% and 47.4% respectively. However, at day 4, the consumption of 
glycerol in MA-treated media started to improve, except for 500 mg/L (1.1%, 6.6% and 
77.2% reduction, respectively). This improvement was in line with the improved metabolite 
production during about the same period. By day 6, 100 mg/L and 300 mg/L of MA produced 
satisfactory amount of lovastatin (8.76 and 8.22 mg/L of lovastatin, respectively), closer to 
what was observed in the positive control at 10.53 mg/L (Figure 5.6). This is quite surprising, 
given that none was produced at earlier time points, and coupled with unfavourable hairless 
morphology. However, the highest concentration of MA (500 mg/L) seemed too toxic to 
produce any lovastatin. At day 9, lovastatin production at both 100 mg/L and 300 mg/L of 
MA significantly exceeded that of the positive control, whereas only a small amount of 
lovastatin was detected at 500 mg/L of MA. Collectively, this observation indicates that MA 
may be interfering with the normal metabolism of fungus, probably by getting involved 
directly in citric acid cycle, by bypassing the pyruvate and the need to use up energy in 
GADPH reaction, resulting in lower substrate consumption and lovastatin production at the 
early stage of active fungal growth. However, MA becomes  stimulatory as the fungus enters 
the later phase (possibly stationary) as A. terreus became more adaptive to the presence of 
MA.  
The production of (+)-geodin and sulochrin in 100 mg/L and 300 mg/L followed a similar 
pattern as lovastatin production (inhibition at early stage but stimulation at later stage), while 
the highest concentration of MA (500 mg/L) was still inhibitory to these metabolites (Figure 
5.9). At 100 mg/L and 300 mg/L MA, none of these metabolites were detected at day 3. At 
day 6, the production in 100 mg/L MA improved (CGEO = 15.76 mg/L; CSUL = 7.67 mg/L), 
although it was still lower than positive control (CGEO = 32.71 mg/L; CSUL = 19.96 mg/L). 
  
 
However, at day 9, the production in both 100 mgL and 300 mg/L was significantly higher 
than positive control production. Their increase of production of (+)-geodin compared to 
control, in terms of percentage at 100 and 300 mg/L MA (MAGEO100 = 347%; MAGEO300 = 
250%)  was even higher when compared to lovastatin’s percentage increase (MALOV100 = 
208%; MALOV300 = 117%). Although the increase was also evident in sulochrin, the 
percentages were much lower (MASUL100 = 179%; MASUL300 = 24.7%). This finding is unlike 
previous observation where sulochrin dominated towards the end of cultivation and reduction 
of (+)-geodin happened as soon as day 6 (also evident in control experiment in Figure 5.9). 
This phenomenon is likely caused by the continual supply of precursors by MA, which 
shifted the equalibrium of metabolite production from sulochrin to (+)-geodin. 
  
  
 
 
 
Figure 5.9: Lovastatin, (+)- geodin and sulochrin production by A. terreus during the 9-
days cultivation. The open symbols represent treatments while the filled symbols represent 
the negative control. A) Lovastatin production, B) (+)-geodin production and C) sulochrin 
production.  
  
 
5.2.2 Fungal pellet structure and integrity are related to (+)-geodin’s production 
This experimental model is devised to examine the role of physical elicition or pellet integrity 
in stimulating the production of metabolites. To aid in breaking the pellet by friction, a linen 
cloth was placed at the bottom of the flask while shaking the culture continuously. The 
experimental method for sonication is described in the Materials and Methods section. As 
expected, the introduction of both the friction and sonication in the cultivation system did not 
return favourable morphological observation. Although biomass was slightly reduced (8.1 
g/L) compared to the negative control (9.0 g/L), the size of the pellet, when friction was used, 
became extremely small, ranging below 0.5 mm, which was caused by the breakage of the 
pellet. The use of sonication produced dispersed hyphae morphology (biomass = 6.1 g/L). 
Dispersed morphology is defined as a morphology where no visible pellet is present, and the 
hyphae are freely dispersed in the medium [135]. 
Surprisingly, it seemed that the pellet in both conditions was still alive until the end of 
cultivation, as the continual production of metabolites was observed until the end of 
cultivation (Figure 5.10). Initially, production of lovastatin in both treatments was similar to 
what has been observed in the control experiment. Unexpectedly, as the fungus entered the 
sixth day of cultivation, lovastatin production was up by 7-fold when friction was used. In 
contrast, the application of sonicator on the cultivation significantly reduced lovastatin 
production, by 40% at day 9. It seems that there are different mechanisms in effect for 
lovastatin, (+)-geodin and sulochrin production in both types of cultivation, even though the 
integrity of the fungal pellet was disrupted. The cause of this increase in production while 
using friction is currently unknown, although several hypotheses can be made. Firstly, in 
cultivation using friction, the breakage of the pellet was not as detrimental as in that of a 
sonicator, and the morphology produced was still in pellet form, albeit very small. Smaller 
  
 
pellet has been shown to be more efficient in producing lovastatin [43,44]. Bizukojc et al. 
argued that smaller A. terreus pellet would retain the higher active area of lovastatin 
production [43], although his team never studied pellets below the size of 1 mm. This 
hypothesis is supported by the significantly higher uptake of glycerol, as shown in Figure 
5.11. Furthermore, the higher surface to volume ratio is another factor that most likely 
contributes to higher intake of glycerol. In sonication experiment, the breakage was very 
sudden and was observed within 24 hours after initial cultivation, which resulted in dispersed 
morphology. The dispersed morphology was known to be unfavourable to the production of 
lovastatin [35].  
The most interesting observation was the production of (+)-geodin and sulochrin when 
friction was used. This time, initial observation based on physical observation already 
indicates that these metabolites were probably being produced in excess, as the media turned 
dark brown when friction was used. Further analysis showed that (+)-geodin was produced 
up to 12-fold while sulochrin was produced up to 5-fold when compared to the positive 
control at day 6. Impressively, although the increase was only 16.9% from day 6, (+)-geodin 
was still being produced continuously at day 9 unlike our control experiment (reduced 
production after day 6).  Similar to what has been observed in the production of lovastatin, 
the production of (+)-geodin and sulochrin was very low under sonication treatment. 
Although slightly higher level of metabolites were still evident, their increment was not as 
significant as what has been observed when friction was used. The dispersed morphology 
created by sonication is most likely the reason the fungus could not emulate the production of 
(+)-geodin and sulochrin when friction was used. 
As discussed before, one of the factors that stimulate the production of (+)-geodin is most 
likely shear stress. Due to the continual stress placed on the fungal pellet due to movement of 
  
 
liquid, and friction with the cloth, it is possible that (+)-geodin’s production is under constant 
stimulation. It is unlikely that this significant increase of metabolites occurred because the 
intracellular metabolites were released once the pellet was burst open. Firstly, during the 
initial breakage of pellet observed as early as day 2, the metabolite amount at day 3 were not 
as high as expected. Secondly, the metabolites were being produced consistently until the end 
of cultivation, even after the pellet broke into small pieces without any further observable 
breakage.  
  
 
  
Figure 5.10: The metabolite production profile of A. terreus under the effect of 
sonication and friction. The disruption of pellet integrity by friction (linen cloth) affects the 
production of (+)-geodin and sulochrin the most, where a substantial amount of these 
metabolites was produced. A) Lovastatin production, B) (+)-geodin production and C) 
sulochrin production. 
  
 
 
Figure 5.11: Glycerol consumption profile of A. terreus under the effect of sonication and 
friction. The rate of consumption was reduced in sonication, but increased when friction was 
used.  
 
5.3 Conclusion 
 
In this chapter, a more thorough investigation on the possible role of lovastatin, (+)-geodin 
and sulochrin was conducted in the form of elicitors. We found that lovastatin and sulochrin 
were induced strongly in the presence of SA and cholesterol. (+)-geodin (and sulochrin, to 
some extent) was more responsive to physical elicitors. The presence of abundant precursors 
may also favour more (+)-geodin, compared to lovastatin and sulochrin. This observation 
confirms the finding in the previous chapters, where (+)-geodin and sulochrin were 
implicated to be involved in the stress-related mechanism of A. terreus. The pattern of 
production also suggested that lovastatin and sulochrin is more closely related than initially 
thought.      
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Chapter 6: Final discussion and future direction 
6.0 Final discussion 
Initial studies in this thesis characterised the production of lovastatin, (+)-geodin and 
sulochrin by A. terreus using a range of substrates/carbon sources and nitrogen sources, two 
major factors that influence metabolite production (discussed in Chapter 1, section 1.2.4). Of 
note, our findings show that better lovastatin production can be achieved using carbon 
sources that are abundant in nature (such as fructose and xylose). Furthermore, lovastatin 
production is not dependent on the rate of carbon consumption, as initially thought [49]. In 
contrast, (+)-geodin and sulochrin production is more dependent on the rate of carbon 
consumption, as slower metabolised carbon sources stimulate the production of these 
metabolites The production of (+)-geodin and sulochrin is also greatly influenced by the 
nitrogen source, compared to lovastatin. Amongst the substrates investigated, glycerol 
showed a satisfactory production of lovastatin, (+)-geodin and sulochrin, and is, therefore, a 
suitable substrate to be used for subsequent work in this study. 
Glycerol is commonly used to study the production of lovastatin by A. terreus, with limited 
information on (+)-geodin and sulochrin production. CG is an example of industrial wastes 
available in excess, and is, therefore, a cheaper alternative. To our knowledge, this is the first 
study to investigate the potential of CG as the substrate for the production of these 
metabolites by A. terreus. Fungi belonging to the Aspergillus genus are known to have high 
resistance to harsh conditions. Therefore, we hypothesised that A. terreus could tolerate the 
presence of impurities in CG. As expected, biomass growth was comparable to PG. However, 
lovastatin production was inhibited, while (+)-geodin and sulochrin production was 
stimulated. These results suggest that the contaminants present in CG inhibit the biosynthesis 
of lovastatin, yet they triggered the production of the two co-metabolites. Partial purification 
  
 
of CG by pre-treatment with activated carbon was able to normalise the production of these 
metabolites (comparable to PG). Notably, our findings highlight that the presence of single or 
double-bonded fatty acids in CG may have differential effects on metabolite production. Pre-
treatment with petroleum ether, which is known to remove mainly saturated fatty acids [118], 
augmented lovastatin production and normalised (+)-geodin and sulochrin production. 
Consistent with this finding, treatment with oleic acid (unsaturated) in culture using PG as the 
substrate increased the production of these three metabolites, whereas treatment with PA 
(saturated) inhibited their production. These results suggest that contaminants other than fatty 
acids may be responsible for the augmented production of (+)-geodin and sulochrin in CG.  
Given that purification of CG by pre-treatment with activated carbon showed that lovastatin, 
(+)-geodin and sulochrin production was comparable to that of PG, this was used as the 
substrate in subsequent investigations. The effects of several factors including ‘elicitors’ and 
malonic acid (MA), on the production of the three metabolites, were studied. Elicitors are 
compounds that can provoke the defense mechanism of microorganisms, which in turn 
activates the production of secondary metabolites. Our findings revealed that chemical 
elicitors may provoke the production of lovastatin and sulochrin, but not (+)-geodin; 
suggesting that lovastatin and sulochrin may have a protective role in A. terreus.  The 
production of all three metabolites was also increased in response to a high shear force 
(physical elicitor), however (+)-geodin’s production, in particular, was increased up to 12-
fold.  This suggests that (+)-geodin may play an important role in the regulation of pellet 
integrity or response to physical injury. The use of cholesterol under the assumption it may 
act as a chemical elicitor were likely to be unsuccessful, due to the pattern difference 
compared to the previous investigations. This pattern may be attributed to positive effects of 
cholesterol on growth, as indicated by increased biomass and optimal hair growth.  
  
 
In conclusion, there is a large potential for the use of bio-waste substrates such as CG in A. 
terreus cultivation and metabolite production, provided that the substrate is subjected to 
appropriate purification. This work also provides new insights into the production pattern of 
lovastatin, (+)-geodin and sulochrin by A. terreus. Lovastatin and sulochrin were shown to be 
more closely related to each other, while  (+)-geodin was produced more situationally.   
  
  
 
6.1 Future direction 
This thesis has demonstrated a promising potential for CG to be used as the substrate for A. 
terreus cultivation and metabolite production under specific conditions. Future directions for 
this work include: 
(1) Further investigation into the methods of purification to enhance the quality of CG. 
As shown in Chapter 4, subsection 4.4.1, pre-treatments with specific solvents can improve 
the production of metabolites. Specifically, new methods of purification could be identified 
and optimised, along with an analysis of the quality and content of purified CG after the pre-
treatments. For example, the use of several established methods in wastewater treatments, 
such as brine treatment, oil and grease removal, removal of organics and biodegradable 
organic, activated sludge process, trickling filter process, treatment of acids, alkalis and toxic 
materials can be performed on CG to improve its quality for fungal cultivation.   
(2) Further investigation into the effect of specific fatty acids on the production of 
metabolites by A.terreus. Specifically, the type of fatty acids and their content in raw and 
purified CG could be analysed by performing Gas Chromatography-Mass Spectrometry 
(GCMS), as described previously [116], [68] and [94]. Subsequent studies could be 
performed to study the effects of identified fatty acids on the production of metabolites in A. 
terreus culture.  
(3) Further investigation into the role of sulochrin and (+)-geodin in A. terreus, and 
identification of other main co-metabolites that may be related to lovastatin biosynthesis 
pathway. The HPLC analysis in appendices showed the presence of an additional compound, 
together with the three metabolites studied.  It may be interesting to identify this compound 
and assess its significance. This can be performed by comparing the known standards of 
  
 
HPLC with the unknown peak. Subsequently, the identity of the compound can be confirmed 
using GCMS.  
(4) Detailed assessment and characterisation of morphological changes of fungal pellets, 
and their influence on metabolites production. Features such as the size and presence of hair 
were examined in most of this study. Other features such as hair length [35] could be 
measured, and the active sites on the fungal pellet [43] could be determined. These studies 
would increase our understanding of the relationship between specific metabolites and the 
morphological features of A. terreus, and their significance. 
(5) Characterisation of the expression of genes important for the biosynthesis of 
lovastatin and its co-metabolites in A. terreus, other than the lovB gene (discussed in Chapter 
1 and Chapter 3). These studies would increase our understanding of their synthetic pathways 
and may lead to better strategies to improve the production of the metabolite(s) of interest.  
(6) To genetically-engineered A. terreus strain to optimize the metabolite production. 
Specifically, the overexpression of several pathways, such as precursor’s production pathway 
(Malonyl-CoA, Acetyl-CoA) may increase the production of metabolites. Similarly, the 
under expression of certain pathways, such as the reduction of the fatty acid biosynthetic 
pathway, may cause more carbon flux towards the metabolite production. The improvement 
can also be made in other departments, such as in the area of survivability or the ability to 
take up the foreign substrate. For example, A. terreus can be made more resistant to the 
inhibitory compound found in CG, and can take up the CG more efficiently.      
(7) Characterisation of the nitrogen consumption to clarify the link between the types of 
nitrogen source, the rate of consumption and metabolite production (refer to Chapter 3, 
subsection 3.2). In this work, only carbon consumption was quantified due to the lack of 
necessary equipment. The analysis of nitrogen would provide a better understanding of the 
  
 
production of (+)-geodin and sulochrin as it was shown that these metabolites are more 
dependent on nitrogen source. 
(8) The investigation into the effects of sonication using low frequency or pulse 
sonication on metabolites production. Given that these methods are less likely to cause 
dispersed morphology (refer to chapter 5, subsection 5.5.2), compared to the continuous 
sonication, the production metabolites is likely to improve as a result of increased release of 
intracellular products, as described previously [47].  
(9) An extended study into the potential of other industrial wastes composed of better 
carbon sources than glycerol for A. terreus cultivation. Our initial screening of a range of 
carbon source revealed that fructose and xylose are more optimal for A. terreus cultivation 
and metabolite production. It is, therefore, worthwhile to investigate whether bio-waste 
products such as whey and waste beet pulp may be more beneficial for A. terreus cultivation 
and could improve the production of metabolite of interest such as lovastatin.  
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Appendices 
Crude glycerol MSDS and content
 
  
 
 
The source of crude glycerol used, and the initial analysis from the company. 
  
  
 
HPLC optimization and standard curve 
 
 
  
Top left: Example of analysis of samples, showing lovastatin, (+)-geodin, sulochrin. Top 
left: The HPLC chromatogram showing major metabolite peaks. (1) correspond to sulochrin, 
(2) is unknown, (3) is (+)-geodin and (4) is lovastatin. Top right: lovastatin standard peak. 
Bottom left: (+)-geodin standard peak. Small peak was detected as results of breakdown after 
prolong storage. Bottom right: Sulochrin standard peak. 
  
  
 
Inductively coupled plasma mass spectrometry (ICP) elements and preparation 
Element Conc (mg/L) 1
st
 dil 2
nd
 dil 3
rd
 dilution 
Al 40 20 10 5 
B 100 50 25 12.5 
Ba 40 20 10 5 
Be 10 5 2.5 1.25 
Cd 10 5 2.5 1.25 
Co 10 5 2.5 1.25 
Cr 20 10 5 2.5 
Cu 20 10 5 2.5 
Fe 100 50 25 12.5 
Mn 10 5 2.5 1.25 
Ni 20 10 5 2.5 
Pb 40 20 10 5 
Se 100 50 25 12.5 
TI 100 50 25 12.5 
V 40 20 10 5 
Zn 100 50 25 12.5 
The heavy metals elements and the concentration used for ICP analysis. The elements of 
interest are in bold. 
  
  
 
Real-time RT PCR 
 
Examples of melt curve generated by Rotor Gene software. Note that there were two 
different peaks, which indicates that the primer bind at two different spots in the genome. 
 
Gene Gene accession 
number 
Oligonucleotide sequence 5’3’ Size 
(bp) 
lovB ATEG_09961 forward: CCG CCT TAA TGA TTG CTG GC 
reverse: ACG TCA GCT GTC AGG TTG AG 
110 
β-actin ATEG_06973 forward: CTT CCC CTC CAT TGT CGG TC 
reverse: TGG GGT ATC TGA GGG TGA GG 
182 
The different primer pairs utilised in real time RT-PCR. All primers were constructed 
using Primer3 software. 
  
  
 
Primer validation and optimization 
 
The example of report generated by RT-PCR software during primer optimization 
procedure showing a) Serial dilution of lovB b) R
2 
value and c) Threshold point was set up 
at 0.089.  
  
  
 
 
Comparison of reaction efficiencies of lovB with β-actin. A linear regression with slope, 
m≤±0.1 indicates that PCR efficiencies were equal. 
 
 lovB β-actin 
Reaction Efficiency (%) 80 94 
Reproducibility (R
2
) 0.99 0.97 
Reaction efficiency and reproducibility values for each of the standard curves generated 
for the genes of interest and endogenous reference gene. The optimum reaction efficiency 
should fall in between 80% to 110%, while the reproducibility (R
2
) for each standard curve 
should be around 0.99. 
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